WO2005047472A2 - Increasing seed threonine content through alteration of threonine aldolase activity - Google Patents
Increasing seed threonine content through alteration of threonine aldolase activity Download PDFInfo
- Publication number
- WO2005047472A2 WO2005047472A2 PCT/US2004/037369 US2004037369W WO2005047472A2 WO 2005047472 A2 WO2005047472 A2 WO 2005047472A2 US 2004037369 W US2004037369 W US 2004037369W WO 2005047472 A2 WO2005047472 A2 WO 2005047472A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- seq
- nucleic acid
- plant
- threonine
- acid molecule
- Prior art date
Links
- 108010043428 Glycine hydroxymethyltransferase Proteins 0.000 title claims abstract description 195
- 102000002667 Glycine hydroxymethyltransferase Human genes 0.000 title claims abstract description 166
- 239000004473 Threonine Substances 0.000 title claims abstract description 83
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 title claims abstract description 81
- 230000001965 increasing effect Effects 0.000 title claims abstract description 54
- 230000000694 effects Effects 0.000 title description 35
- 230000004075 alteration Effects 0.000 title description 4
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 213
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 209
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 209
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims abstract description 154
- 238000000034 method Methods 0.000 claims abstract description 142
- 230000014509 gene expression Effects 0.000 claims abstract description 73
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract description 65
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims abstract description 43
- 229960000310 isoleucine Drugs 0.000 claims abstract description 43
- 230000008685 targeting Effects 0.000 claims abstract description 30
- 238000004519 manufacturing process Methods 0.000 claims abstract description 25
- 230000002438 mitochondrial effect Effects 0.000 claims abstract description 25
- 241001465754 Metazoa Species 0.000 claims abstract description 14
- 239000013604 expression vector Substances 0.000 claims abstract description 11
- 241000196324 Embryophyta Species 0.000 claims description 482
- 150000001413 amino acids Chemical group 0.000 claims description 136
- 108090000623 proteins and genes Proteins 0.000 claims description 110
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 claims description 83
- 230000009261 transgenic effect Effects 0.000 claims description 81
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 claims description 77
- 230000035772 mutation Effects 0.000 claims description 63
- 230000009466 transformation Effects 0.000 claims description 62
- 102000004190 Enzymes Human genes 0.000 claims description 55
- 108090000790 Enzymes Proteins 0.000 claims description 55
- 108020004414 DNA Proteins 0.000 claims description 47
- 239000013598 vector Substances 0.000 claims description 37
- 240000008042 Zea mays Species 0.000 claims description 36
- 235000010469 Glycine max Nutrition 0.000 claims description 33
- 230000030279 gene silencing Effects 0.000 claims description 33
- 244000068988 Glycine max Species 0.000 claims description 31
- 230000015572 biosynthetic process Effects 0.000 claims description 31
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 30
- 239000002773 nucleotide Substances 0.000 claims description 30
- 241000219195 Arabidopsis thaliana Species 0.000 claims description 29
- 125000003729 nucleotide group Chemical group 0.000 claims description 29
- 240000007594 Oryza sativa Species 0.000 claims description 23
- 235000007164 Oryza sativa Nutrition 0.000 claims description 22
- 230000000692 anti-sense effect Effects 0.000 claims description 22
- 235000009566 rice Nutrition 0.000 claims description 21
- 241000589158 Agrobacterium Species 0.000 claims description 20
- 238000013518 transcription Methods 0.000 claims description 20
- 230000035897 transcription Effects 0.000 claims description 20
- 231100000350 mutagenesis Toxicity 0.000 claims description 19
- 108700007698 Genetic Terminator Regions Proteins 0.000 claims description 18
- 238000003780 insertion Methods 0.000 claims description 18
- 230000037431 insertion Effects 0.000 claims description 18
- 108010000700 Acetolactate synthase Proteins 0.000 claims description 17
- 240000003768 Solanum lycopersicum Species 0.000 claims description 17
- 239000013612 plasmid Substances 0.000 claims description 17
- 244000061456 Solanum tuberosum Species 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 16
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 15
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 15
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 15
- 230000001404 mediated effect Effects 0.000 claims description 15
- 241000208125 Nicotiana Species 0.000 claims description 14
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 14
- 108010006873 Threonine Dehydratase Proteins 0.000 claims description 14
- 238000002703 mutagenesis Methods 0.000 claims description 14
- 230000006870 function Effects 0.000 claims description 13
- 230000001939 inductive effect Effects 0.000 claims description 13
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 12
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 12
- 240000001980 Cucurbita pepo Species 0.000 claims description 12
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims description 11
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 11
- 240000000385 Brassica napus var. napus Species 0.000 claims description 11
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims description 11
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims description 11
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims description 11
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 11
- 241000209140 Triticum Species 0.000 claims description 11
- 235000021307 Triticum Nutrition 0.000 claims description 11
- 108020004999 messenger RNA Proteins 0.000 claims description 11
- 230000001629 suppression Effects 0.000 claims description 11
- 229920000742 Cotton Polymers 0.000 claims description 10
- 241000219146 Gossypium Species 0.000 claims description 10
- 239000012190 activator Substances 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 claims description 10
- -1 polyethylene Polymers 0.000 claims description 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 240000002791 Brassica napus Species 0.000 claims description 9
- 235000011293 Brassica napus Nutrition 0.000 claims description 9
- 229920001184 polypeptide Polymers 0.000 claims description 9
- 230000001131 transforming effect Effects 0.000 claims description 9
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 8
- 108090000698 Formate Dehydrogenases Proteins 0.000 claims description 8
- 240000005979 Hordeum vulgare Species 0.000 claims description 8
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 8
- 240000004922 Vigna radiata Species 0.000 claims description 8
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims description 8
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims description 8
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 7
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 235000005822 corn Nutrition 0.000 claims description 7
- 238000004520 electroporation Methods 0.000 claims description 7
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims description 6
- 240000002234 Allium sativum Species 0.000 claims description 6
- 244000099147 Ananas comosus Species 0.000 claims description 6
- 235000007119 Ananas comosus Nutrition 0.000 claims description 6
- 240000007087 Apium graveolens Species 0.000 claims description 6
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims description 6
- 235000010591 Appio Nutrition 0.000 claims description 6
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 6
- 244000105624 Arachis hypogaea Species 0.000 claims description 6
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 6
- 235000018262 Arachis monticola Nutrition 0.000 claims description 6
- 235000000832 Ayote Nutrition 0.000 claims description 6
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 6
- 241000335053 Beta vulgaris Species 0.000 claims description 6
- 240000007124 Brassica oleracea Species 0.000 claims description 6
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 6
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 6
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims description 6
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 6
- 235000002566 Capsicum Nutrition 0.000 claims description 6
- 240000006740 Cichorium endivia Species 0.000 claims description 6
- 235000007542 Cichorium intybus Nutrition 0.000 claims description 6
- 241000219112 Cucumis Species 0.000 claims description 6
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims description 6
- 240000008067 Cucumis sativus Species 0.000 claims description 6
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims description 6
- 235000009852 Cucurbita pepo Nutrition 0.000 claims description 6
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 6
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 claims description 6
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 claims description 6
- 235000009355 Dianthus caryophyllus Nutrition 0.000 claims description 6
- 240000006497 Dianthus caryophyllus Species 0.000 claims description 6
- 240000002395 Euphorbia pulcherrima Species 0.000 claims description 6
- 244000020551 Helianthus annuus Species 0.000 claims description 6
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 6
- 244000017020 Ipomoea batatas Species 0.000 claims description 6
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 6
- 235000003228 Lactuca sativa Nutrition 0.000 claims description 6
- 240000008415 Lactuca sativa Species 0.000 claims description 6
- 241000220225 Malus Species 0.000 claims description 6
- 235000011430 Malus pumila Nutrition 0.000 claims description 6
- 235000015103 Malus silvestris Nutrition 0.000 claims description 6
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 6
- 240000005561 Musa balbisiana Species 0.000 claims description 6
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 6
- 240000004370 Pastinaca sativa Species 0.000 claims description 6
- 235000017769 Pastinaca sativa subsp sativa Nutrition 0.000 claims description 6
- 241000208181 Pelargonium Species 0.000 claims description 6
- 239000006002 Pepper Substances 0.000 claims description 6
- 240000007377 Petunia x hybrida Species 0.000 claims description 6
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 6
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 6
- 235000016761 Piper aduncum Nutrition 0.000 claims description 6
- 240000003889 Piper guineense Species 0.000 claims description 6
- 235000017804 Piper guineense Nutrition 0.000 claims description 6
- 235000008184 Piper nigrum Nutrition 0.000 claims description 6
- 240000004713 Pisum sativum Species 0.000 claims description 6
- 235000010582 Pisum sativum Nutrition 0.000 claims description 6
- 239000004698 Polyethylene Substances 0.000 claims description 6
- 235000014443 Pyrus communis Nutrition 0.000 claims description 6
- 240000001987 Pyrus communis Species 0.000 claims description 6
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims description 6
- 240000000111 Saccharum officinarum Species 0.000 claims description 6
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 6
- 241000209056 Secale Species 0.000 claims description 6
- 235000007238 Secale cereale Nutrition 0.000 claims description 6
- 235000002597 Solanum melongena Nutrition 0.000 claims description 6
- 244000061458 Solanum melongena Species 0.000 claims description 6
- 240000003829 Sorghum propinquum Species 0.000 claims description 6
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 6
- 235000009337 Spinacia oleracea Nutrition 0.000 claims description 6
- 244000300264 Spinacia oleracea Species 0.000 claims description 6
- 241001112810 Streptocarpus Species 0.000 claims description 6
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 6
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 6
- 240000006365 Vitis vinifera Species 0.000 claims description 6
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 6
- 240000003307 Zinnia violacea Species 0.000 claims description 6
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims description 6
- 235000003733 chicria Nutrition 0.000 claims description 6
- 235000004611 garlic Nutrition 0.000 claims description 6
- 230000008595 infiltration Effects 0.000 claims description 6
- 238000001764 infiltration Methods 0.000 claims description 6
- 238000000520 microinjection Methods 0.000 claims description 6
- 235000020232 peanut Nutrition 0.000 claims description 6
- 229920000573 polyethylene Polymers 0.000 claims description 6
- 235000015136 pumpkin Nutrition 0.000 claims description 6
- 235000020354 squash Nutrition 0.000 claims description 6
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 claims description 5
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical group CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 claims description 5
- 108020004166 alternative oxidase Proteins 0.000 claims description 5
- 230000005855 radiation Effects 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 241000207199 Citrus Species 0.000 claims description 4
- 235000020971 citrus fruits Nutrition 0.000 claims description 4
- 230000000415 inactivating effect Effects 0.000 claims description 4
- 239000003471 mutagenic agent Substances 0.000 claims description 4
- 210000000056 organ Anatomy 0.000 claims description 4
- 230000001902 propagating effect Effects 0.000 claims description 4
- 238000002741 site-directed mutagenesis Methods 0.000 claims description 4
- 240000007651 Rubus glaucus Species 0.000 claims description 3
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 3
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 3
- 238000012217 deletion Methods 0.000 claims description 3
- 230000037430 deletion Effects 0.000 claims description 3
- 235000002767 Daucus carota Nutrition 0.000 claims description 2
- 244000000626 Daucus carota Species 0.000 claims description 2
- 238000002744 homologous recombination Methods 0.000 claims description 2
- 230000006801 homologous recombination Effects 0.000 claims description 2
- 150000003588 threonines Chemical class 0.000 claims description 2
- 241000234282 Allium Species 0.000 claims 5
- 241000723343 Cichorium Species 0.000 claims 5
- 241000219823 Medicago Species 0.000 claims 5
- 241000220259 Raphanus Species 0.000 claims 5
- 102000013379 Mitochondrial Proton-Translocating ATPases Human genes 0.000 claims 2
- 108010026155 Mitochondrial Proton-Translocating ATPases Proteins 0.000 claims 2
- 108700026220 vif Genes Proteins 0.000 claims 2
- 235000004221 Brassica oleracea var gemmifera Nutrition 0.000 claims 1
- 244000308368 Brassica oleracea var. gemmifera Species 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 description 111
- 229940024606 amino acid Drugs 0.000 description 110
- 210000004027 cell Anatomy 0.000 description 90
- 229960002898 threonine Drugs 0.000 description 73
- 241000219194 Arabidopsis Species 0.000 description 71
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 70
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 38
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 37
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 34
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 34
- 238000003556 assay Methods 0.000 description 30
- 230000002441 reversible effect Effects 0.000 description 28
- 239000004471 Glycine Substances 0.000 description 26
- 210000001519 tissue Anatomy 0.000 description 26
- 102000004169 proteins and genes Human genes 0.000 description 24
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 23
- 235000009973 maize Nutrition 0.000 description 23
- 235000018102 proteins Nutrition 0.000 description 23
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 22
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 21
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
- 239000004472 Lysine Substances 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 16
- 238000012226 gene silencing method Methods 0.000 description 16
- 238000004128 high performance liquid chromatography Methods 0.000 description 16
- 101000643834 Cavia porcellus 3-beta-hydroxysteroid sulfotransferase Proteins 0.000 description 15
- 102100028075 Fibroblast growth factor 6 Human genes 0.000 description 15
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 15
- 238000010367 cloning Methods 0.000 description 15
- 210000003470 mitochondria Anatomy 0.000 description 14
- 230000037361 pathway Effects 0.000 description 14
- 230000001105 regulatory effect Effects 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 238000013459 approach Methods 0.000 description 13
- 238000000605 extraction Methods 0.000 description 13
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 12
- 210000000349 chromosome Anatomy 0.000 description 12
- 238000005259 measurement Methods 0.000 description 12
- 229930182817 methionine Natural products 0.000 description 12
- 229960004452 methionine Drugs 0.000 description 12
- 230000002068 genetic effect Effects 0.000 description 11
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 10
- 108010055400 Aspartate kinase Proteins 0.000 description 10
- 241000588724 Escherichia coli Species 0.000 description 10
- 102000019394 Serine hydroxymethyltransferases Human genes 0.000 description 10
- 108700019146 Transgenes Proteins 0.000 description 10
- 230000033228 biological regulation Effects 0.000 description 10
- 244000038559 crop plants Species 0.000 description 10
- 230000009368 gene silencing by RNA Effects 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 150000007513 acids Chemical class 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 108700028369 Alleles Proteins 0.000 description 8
- 125000000393 L-methionino group Chemical group [H]OC(=O)[C@@]([H])(N([H])[*])C([H])([H])C(SC([H])([H])[H])([H])[H] 0.000 description 8
- 108010061618 O-succinylhomoserine (thiol)-lyase Proteins 0.000 description 8
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 8
- 150000005693 branched-chain amino acids Chemical class 0.000 description 8
- 238000012512 characterization method Methods 0.000 description 8
- 239000002299 complementary DNA Substances 0.000 description 8
- 238000001212 derivatisation Methods 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 230000004927 fusion Effects 0.000 description 8
- 238000013507 mapping Methods 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 7
- 229940009098 aspartate Drugs 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 230000002255 enzymatic effect Effects 0.000 description 7
- 230000002779 inactivation Effects 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 230000004060 metabolic process Effects 0.000 description 7
- 238000012552 review Methods 0.000 description 7
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 6
- 108091000044 4-hydroxy-tetrahydrodipicolinate synthase Proteins 0.000 description 6
- 108700001094 Plant Genes Proteins 0.000 description 6
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 6
- 101710084636 Serine hydroxymethyltransferase Proteins 0.000 description 6
- 101710099809 Serine hydroxymethyltransferase, cytosolic Proteins 0.000 description 6
- 102100021225 Serine hydroxymethyltransferase, cytosolic Human genes 0.000 description 6
- 101710087362 Serine hydroxymethyltransferase, mitochondrial Proteins 0.000 description 6
- 108010022394 Threonine synthase Proteins 0.000 description 6
- 235000007244 Zea mays Nutrition 0.000 description 6
- 238000009825 accumulation Methods 0.000 description 6
- 230000000295 complement effect Effects 0.000 description 6
- 210000002257 embryonic structure Anatomy 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000004907 flux Effects 0.000 description 6
- 238000010353 genetic engineering Methods 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 210000001938 protoplast Anatomy 0.000 description 6
- 230000008929 regeneration Effects 0.000 description 6
- 238000011069 regeneration method Methods 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 102000003677 Aldehyde-Lyases Human genes 0.000 description 5
- 108090000072 Aldehyde-Lyases Proteins 0.000 description 5
- 101100337028 Arabidopsis thaliana GLX2-1 gene Proteins 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- 241000701489 Cauliflower mosaic virus Species 0.000 description 5
- 101150108526 GLY1 gene Proteins 0.000 description 5
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 102000006843 Threonine synthase Human genes 0.000 description 5
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 5
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 5
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 239000000411 inducer Substances 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 239000002207 metabolite Substances 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 238000010369 molecular cloning Methods 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 238000012261 overproduction Methods 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 238000005204 segregation Methods 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 238000001712 DNA sequencing Methods 0.000 description 4
- 235000014718 Gossypium raimondii Nutrition 0.000 description 4
- 241001149081 Gossypium raimondii Species 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- 206010020649 Hyperkeratosis Diseases 0.000 description 4
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- 108700026244 Open Reading Frames Proteins 0.000 description 4
- 102000001253 Protein Kinase Human genes 0.000 description 4
- 102100026115 S-adenosylmethionine synthase isoform type-1 Human genes 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000002363 herbicidal effect Effects 0.000 description 4
- 239000004009 herbicide Substances 0.000 description 4
- 230000008676 import Effects 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 229960003646 lysine Drugs 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 108010037870 Anthranilate Synthase Proteins 0.000 description 3
- 101710088194 Dehydrogenase Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 102000053187 Glucuronidase Human genes 0.000 description 3
- 108010060309 Glucuronidase Proteins 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
- 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- 108030003181 Low-specificity L-threonine aldolases Proteins 0.000 description 3
- 241000209094 Oryza Species 0.000 description 3
- 108050006939 Serine hydroxymethyltransferases Proteins 0.000 description 3
- 108091027967 Small hairpin RNA Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- 244000098338 Triticum aestivum Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000037354 amino acid metabolism Effects 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000010455 autoregulation Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000001851 biosynthetic effect Effects 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000004807 desolvation Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 238000007824 enzymatic assay Methods 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000012215 gene cloning Methods 0.000 description 3
- 239000003862 glucocorticoid Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 108010058731 nopaline synthase Proteins 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000004885 tandem mass spectrometry Methods 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 230000010474 transient expression Effects 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 230000017105 transposition Effects 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- MUVQIIBPDFTEKM-IUYQGCFVSA-N (2r,3s)-2-aminobutane-1,3-diol Chemical compound C[C@H](O)[C@H](N)CO MUVQIIBPDFTEKM-IUYQGCFVSA-N 0.000 description 2
- ZTTWHZHBPDYSQB-LBPRGKRZSA-N (2s)-2-amino-3-(1h-indol-3-yl)-2-methylpropanoic acid Chemical compound C1=CC=C2C(C[C@@](N)(C)C(O)=O)=CNC2=C1 ZTTWHZHBPDYSQB-LBPRGKRZSA-N 0.000 description 2
- MSTNYGQPCMXVAQ-RYUDHWBXSA-N (6S)-5,6,7,8-tetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1)N)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-RYUDHWBXSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 108020005544 Antisense RNA Proteins 0.000 description 2
- 108700003860 Bacterial Genes Proteins 0.000 description 2
- 240000006432 Carica papaya Species 0.000 description 2
- 235000009467 Carica papaya Nutrition 0.000 description 2
- 108091035707 Consensus sequence Proteins 0.000 description 2
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 150000008575 L-amino acids Chemical class 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 108030001992 L-threonine aldolases Proteins 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 241000218922 Magnoliophyta Species 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 108700008625 Reporter Genes Proteins 0.000 description 2
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 2
- 102100028294 Saccharopine dehydrogenase Human genes 0.000 description 2
- 108010039811 Starch synthase Proteins 0.000 description 2
- 241000204666 Thermotoga maritima Species 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 229960001570 ademetionine Drugs 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 230000003281 allosteric effect Effects 0.000 description 2
- 238000011948 assay development Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000001925 catabolic effect Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000013611 chromosomal DNA Substances 0.000 description 2
- 239000003184 complementary RNA Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 229910052805 deuterium Inorganic materials 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000009088 enzymatic function Effects 0.000 description 2
- 239000011536 extraction buffer Substances 0.000 description 2
- 230000009123 feedback regulation Effects 0.000 description 2
- IRXSLJNXXZKURP-UHFFFAOYSA-N fluorenylmethyloxycarbonyl chloride Chemical compound C1=CC=C2C(COC(=O)Cl)C3=CC=CC=C3C2=C1 IRXSLJNXXZKURP-UHFFFAOYSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 238000003205 genotyping method Methods 0.000 description 2
- 125000004383 glucosinolate group Chemical group 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000037353 metabolic pathway Effects 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000011859 microparticle Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000005097 photorespiration Effects 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- 108020000318 saccharopine dehydrogenase Proteins 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000030118 somatic embryogenesis Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000004114 suspension culture Methods 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000005460 tetrahydrofolate Substances 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- PVJADZQYWZQYBF-UHNVWZDZSA-N (2s,3r)-2-amino-3-(2-oxopropanoyloxy)butanoic acid Chemical compound OC(=O)[C@@H](N)[C@@H](C)OC(=O)C(C)=O PVJADZQYWZQYBF-UHNVWZDZSA-N 0.000 description 1
- SXGMVGOVILIERA-HRFVKAFMSA-N (2s,3s)-2,3-diaminobutanoic acid Chemical compound C[C@H](N)[C@H](N)C(O)=O SXGMVGOVILIERA-HRFVKAFMSA-N 0.000 description 1
- 101150084750 1 gene Proteins 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- WYMDDFRYORANCC-UHFFFAOYSA-N 2-[[3-[bis(carboxymethyl)amino]-2-hydroxypropyl]-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)CN(CC(O)=O)CC(O)=O WYMDDFRYORANCC-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- XHYVBIXKORFHFM-UHFFFAOYSA-N 2-amino-6-methylbenzoic acid Chemical compound CC1=CC=CC(N)=C1C(O)=O XHYVBIXKORFHFM-UHFFFAOYSA-N 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 description 1
- 101150090724 3 gene Proteins 0.000 description 1
- OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- RWWZYORFHGIOOC-UHFFFAOYSA-N 5-chloro-6-[4-(2-hydroxyethyl)piperidin-1-yl]-1h-pyrimidine-2,4-dione Chemical compound C1CC(CCO)CCN1C1=NC(O)=NC(O)=C1Cl RWWZYORFHGIOOC-UHFFFAOYSA-N 0.000 description 1
- GMVPRGQOIOIIMI-DODZYUBVSA-N 7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DODZYUBVSA-N 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 241000256182 Anopheles gambiae Species 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 108020004491 Antisense DNA Proteins 0.000 description 1
- 101100482664 Arabidopsis thaliana ASA1 gene Proteins 0.000 description 1
- 101001055189 Arabidopsis thaliana Acetolactate synthase, chloroplastic Proteins 0.000 description 1
- 101100062433 Arabidopsis thaliana DHDPS1 gene Proteins 0.000 description 1
- 101100099271 Arabidopsis thaliana THA2 gene Proteins 0.000 description 1
- 101100314835 Arabidopsis thaliana TRP5 gene Proteins 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 108010070255 Aspartate-ammonia ligase Proteins 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- 101100001642 Caenorhabditis elegans amt-1 gene Proteins 0.000 description 1
- 101100290380 Caenorhabditis elegans cel-1 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
- 101710150820 Cellular tumor antigen p53 Proteins 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 102100031655 Cytochrome b5 Human genes 0.000 description 1
- 108010007167 Cytochromes b5 Proteins 0.000 description 1
- 101150074155 DHFR gene Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241000255601 Drosophila melanogaster Species 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 101100437498 Escherichia coli (strain K12) uidA gene Proteins 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 101150094690 GAL1 gene Proteins 0.000 description 1
- 101150038242 GAL10 gene Proteins 0.000 description 1
- 102100028501 Galanin peptides Human genes 0.000 description 1
- 102100024637 Galectin-10 Human genes 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 201000010915 Glioblastoma multiforme Diseases 0.000 description 1
- 229940117892 Glutamate receptor agonist Drugs 0.000 description 1
- 101150009006 HIS3 gene Proteins 0.000 description 1
- 101150021206 HST3 gene Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101100121078 Homo sapiens GAL gene Proteins 0.000 description 1
- 101100216108 Homo sapiens PRMT1 gene Proteins 0.000 description 1
- 101000724404 Homo sapiens Saccharopine dehydrogenase Proteins 0.000 description 1
- 108010064711 Homoserine dehydrogenase Proteins 0.000 description 1
- 102000006933 Hydroxymethyl and Formyl Transferases Human genes 0.000 description 1
- 108010072462 Hydroxymethyl and Formyl Transferases Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- GGLZPLKKBSSKCX-YFKPBYRVSA-N L-ethionine Chemical compound CCSCC[C@H](N)C(O)=O GGLZPLKKBSSKCX-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001508691 Martes zibellina Species 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 108010007784 Methionine adenosyltransferase Proteins 0.000 description 1
- 108010009513 Mitochondrial Aldehyde Dehydrogenase Proteins 0.000 description 1
- 102000009645 Mitochondrial Aldehyde Dehydrogenase Human genes 0.000 description 1
- 108010058682 Mitochondrial Proteins Proteins 0.000 description 1
- 102000006404 Mitochondrial Proteins Human genes 0.000 description 1
- 108010021466 Mutant Proteins Proteins 0.000 description 1
- 102000008300 Mutant Proteins Human genes 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 241000208133 Nicotiana plumbaginifolia Species 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 101710173432 Phytoene synthase Proteins 0.000 description 1
- 108020005089 Plant RNA Proteins 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 102100022985 Protein arginine N-methyltransferase 1 Human genes 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 1
- 108050008511 S-adenosylmethionine synthases Proteins 0.000 description 1
- 101100178218 Schizosaccharomyces pombe (strain 972 / ATCC 24843) hmt2 gene Proteins 0.000 description 1
- 101100036896 Schizosaccharomyces pombe (strain 972 / ATCC 24843) uep1 gene Proteins 0.000 description 1
- 101710197770 Serine hydroxymethyltransferase 1 Proteins 0.000 description 1
- 101710197776 Serine hydroxymethyltransferase 2 Proteins 0.000 description 1
- 241001136583 Solanum pennellii Species 0.000 description 1
- 235000019104 Solanum pennellii var pennellii Nutrition 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- BIYXEUAFGLTAEM-WUJLRWPWSA-N Thr-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(O)=O BIYXEUAFGLTAEM-WUJLRWPWSA-N 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- JUGOREOARAHOCO-UHFFFAOYSA-M acetylcholine chloride Chemical compound [Cl-].CC(=O)OCC[N+](C)(C)C JUGOREOARAHOCO-UHFFFAOYSA-M 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 230000010386 affect regulation Effects 0.000 description 1
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 1
- 230000008848 allosteric regulation Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
- 239000006053 animal diet Substances 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003816 antisense DNA Substances 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 238000010256 biochemical assay Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229940027138 cambia Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000002962 chemical mutagen Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 1
- 239000004062 cytokinin Substances 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002074 deregulated effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000004034 genetic regulation Effects 0.000 description 1
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Natural products O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000011491 glass wool Substances 0.000 description 1
- 208000005017 glioblastoma Diseases 0.000 description 1
- 239000003823 glutamate receptor agonist Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002313 glycerolipids Chemical class 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002743 insertional mutagenesis Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000004777 loss-of-function mutation Effects 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 238000007884 metabolite profiling Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 230000031787 nutrient reservoir activity Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000009894 physiological stress Effects 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 230000036178 pleiotropy Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- 229960001327 pyridoxal phosphate Drugs 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 102000037983 regulatory factors Human genes 0.000 description 1
- 108091008025 regulatory factors Proteins 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 102000002774 saccharopine dehydrogenase Human genes 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 238000012250 transgenic expression Methods 0.000 description 1
- 229940066528 trichloroacetate Drugs 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
- C12N9/1014—Hydroxymethyl-, formyl-transferases (2.1.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
Definitions
- the present invention relates to a nucleic acid constructs configured for enhancement of threonine and isoleucine content in plants, and methods for using these nucleic acid constructs.
- the present invention also relates to methods of increasing threonine and/or isoleucine content in plants.
- Glu, Gin, Asp and Asn are sources of nitrogen and precursors for a wide variety of metabolic pathways. These are also major nitrogen transport molecules that are regulated in response to environmental signals such as light, and may in fact act as signaling molecules in the plant (Brenner et al., "Arabidopsis Mutants Resistant to S(+)-Beta-Methyl- Alpha, Beta-Diaminopropionic Acid, a Cycad-Derived Glutamate Receptor Agonist," Plant Physiol 124: 1615-1624 (2000); Lam et al., "Reciprocal Regulation of Distinct Asparagine Synthetase Genes by Light and Metabolites in Arabidopsis Thaliana," Plant J 16:345-353 (1998)).
- the role of amino acids in plant morphogenesis and stress adaptation is widespread, with a variety of amino acids acting as precursors for the synthesis of hormones and secondary metabolites
- Lys ketoglutarate reductase was also effectively employed to increase Lys levels in Arabidopsis seeds (Zhu et al, "A T-DNA Insertion Knockout of the Bifunctional Lysine-Ketoglutarate Reductase/Saccharopine Dehydrogenase Gene
- Aspartate kinase as the committing enzyme in the pathways is subject to feedback inhibition by the downstream metabolites threonine, s-adenosylmethionine, and lysine (Ben-Tzvi Tzchori et al., "Lysine and Threonine Metabolism Are Subject to Complex Patterns of Regulation in Arabidopsis," Plant Mol Biol 32:727-734 (1996); Rognes et al., "S-Adenosylmethionfne--a Novel Regulator of Aspartate Kinase," Nature 287:357-359 (1980)).
- Elevated threonine levels also inhibit the homoserine dehydrogenase portion of the bi- functional aspartate kinase-homoserine dehydrogenase enzyme (Paris et al., "Mechanism of Control of Arabidopsis Thaliana Aspartate Kinase-Homoserine Dehydrogenase by Threonine," JBiol Chem 278:5361- 5366 (2003)).
- CGS cystathionine gamma-synthase
- CGS cystathionine gamma-synthase
- S-adenosylmethionfne allosterically activates tl reonine synthase, which competes with cystathionine gamma-synthase for the common substrate homeserine 4-phosphate (Curien et al., "Allosteric Activation of Arabidopsis Threonine Synthase by S-Adenosylmethionine," Biochemisti ⁇ 37:13212- 13221 (1998)).
- the present invention relates to a nucleic acid construct having a nucleic acid molecule configured to silence tlireonine aldolase expression.
- the construct also includes a 5' DNA promoter sequence and a 3' terminator sequence.
- the nucleic acid molecule, the promoter, and the terminator are operatively coupled to permit transcription of the nucleic acid molecule.
- Another aspect of the present invention is a method of increasing tlireonine content in a plant. This method involves providing a transgenic plant or plant seed transformed with a nucleic acid construct having a nucleic acid molecule configured to silence threonine aldolase expression, a 5' DNA promoter sequence, and a 3' terminator sequence. The method involves growing the transgenic plant or a transgenic plant grown from the transgenic plant seed under conditions effective to increase the threonine content of the transgenic plant or the plant grown from the transgenic plant seed.
- the present invention also relates to expression vectors, host cells, plant cells, plants, and plant seeds having a nucleic acid molecule configured to silence threonine aldolase expression.
- the present invention further relates to animal feed and foodstuff containing the plant seeds having the nucleic acid molecule configured to silence threonine aldolase expression.
- the present invention also relates to a method of making a mutant plant having an increased level of seed threonine compared to that of a non-mutant plant.
- This method involves providing at least one cell of a non-mutant plant containing a gene encoding a functional threonine aldolase.
- the at least one cell of a non-mutant plant is treated under conditions effective to inactivate the gene, thereby yielding at least one mutant plant cell containing an inactivated threonine aldolase gene.
- the at least one mutant plant cell is propagated into a mutant plant, which has an increased level of seed threonine compared to that of the non-mutant plant.
- the present invention further relates to a nucleic acid construct having a nucleic acid molecule encoding a tlireonine aldolase.
- the construct also includes a mitochondrial targeting sequence, a 5' DNA promoter sequence, and a 3' terminator sequence.
- the nucleic acid molecule encoding a threonine aldolase, the mitochondrial targeting sequence, the promoter, and the terminator are operatively coupled to permit transcription of the nucleic acid molecule.
- Another aspect of the present invention relates to expression vectors, host cells, plant cells, plants, and plant seeds transformed with the nucleic acid molecule a encoding a threonine aldolase.
- the present invention further relates to ariimal feed and foodstuff containing the plant seeds transformed with the nucleic acid molecule a encoding a threonine aldolase.
- Another aspect of the present invention is a method of increasing threonine content in a plant by providing a transgenic plant or plant seed transformed with a nucleic acid construct having a nucleic acid molecule encoding a threonine aldolase, a mitochondrial targeting sequence, a 5' DNA promoter sequence, and a 3' terminator sequence. The method involves growing the transgenic plant or a transgenic plant grown from the transgenic plant seed under conditions effective to increase the tl ⁇ eonine content of the transgenic plant or the plant grown from the transgenic plant seed.
- the present invention also relates to a method of increasing isoleucine content in a plant.
- This method involves providing a non-wild-type plant having increased threonine content compared to a corresponding wild-type plant.
- the non- wild-type plant is transformed with a nucleic acid construct under conditions effective to yield a transgenic plant that overexpresses an enzyme that functions to catalyze biosynthesis of isoleucine from threonine.
- the nucleic acid construct used for this method includes a nucleic acid molecule encoding an enzyme that functions to catalyze biosynthesis of isoleucine from threonine, a 5' DNA promoter sequence, and a 3' terminator sequence.
- the nucleic acid molecule, the promoter, and the terminator are operatively coupled to permit transcription of the nucleic acid molecule.
- the method involves growing the transgenic plant under conditions effective to increase the isoleucine content of the transgenic plant.
- the present invention also relates to a method of identifying a plant having a high seed threonine content.
- This method involves providing a candidate plant.
- the candidate plant is analyzed for the presence, in its genome, of a gene encoding a non-functional threonine aldolase. The presence of the gene indicates that the candidate plant has high seed threonine content.
- Tlireonine and certain other essential amino acids are present in lower than optimal amounts in grains that are widely used as feed for farm animals and also make up the majority of the diet of some human populations (Coruzzi and Last, "Amino Acids," Biochemistry and Molecular Biology of Plants 358-410 (2000)).
- Crop plants with such suboptimal levels of dietary amino acids include com (lysine, tryptophan, and methionine), rice (lysine, isoleucine, and tlireonine), wheat (lysine), potato (isoleucine, methionine, and cysteine) and soy (methionine and threonine).
- Animal feed is often supplemented with relatively expensive chemically synthesized versions of these five amino acids.
- essential amino acids are attractive targets for nutritional improvement through biotechnology.
- a general increase in seed protein would raise the nutritional value of grain crops. Since amino acids are the building blocks of proteins, elevated seed amino acid levels, or import of amino acids into the seeds is a prerequisite to increasing overall seed protein content.
- Altering threonine aldolase activity in plants can be used in various ways for plant improvement. For example, reduction of threonine aldolase enzymatic activity can be used to increase threonine content. As can be observed in the HST2 mutant (discussed herein infra), reduction of threonine aldolase activity can be used to increase seed threonine content. Mutations similar to the HST2 mutation described herein infra could be identified in crop plants. In addition, RNA interference (RNAi) could be used to decrease the level of threonine aldolase to increase threonine levels.
- RNA interference RNA interference
- RNAi constructs could be used to increase levels of threonine in seeds, but not alter the amino acid metabolism of other parts of the plants.
- tlireonine aldolase is a homotetramer (Ogawa et al., "Serine Hydroxymethyltransferase and Tlireonine Aldolase: Are They Identical?," Int J Biochem Cell Biol 32:289-301 (2000))
- tlireonine aldolase to improve crops includes expression of threonine aldolase in mitochondria to increase threonine content.
- the reaction catalyzed by tlireonine aldolase is reversible.
- the reaction could proceed in the direction of threonine.
- Arabidopsis threonine aldolases (described herein infra) are predicted to be cytosolic enzymes.
- the highest glycine content, or at least the highest metabolic flux through glycine, in the plant is likely to be in the mitochondria, where the conversion of glycine to serine by serine hydroxymethyltransferase occurs during photorespiration (Figure 7).
- Expression of threonine aldolase linked to a mitochondrial targeting sequence could be used to redirect some of this flux toward threonine instead of serine. This would increase the level of free threonine in the plant.
- Arabidopsis threonine aldolase, or any other threonine aldolase could be targeted to the mitochondria of a crop plant in this manner.
- tlireonine aldolase to improve crops involves increased threonine as a prerequisite for increasing isoleucine content.
- Threonine serves as a precursor for the biosynthesis of isoleucine ( Figure 8).
- Figure 8 a prerequisite for increasing seed isoleucine content is the production of increased amounts of threonine.
- Alteration of threonine aldolase activity by mutations or RNA interference could be used in conjunction with modification or upregulation of later steps in the pathway leading to isoleucine (e.g. acetolactate synthase) to increase the seed levels of this amino acid.
- Figures 1 A-1C show comparisons of amino acid measurement by
- HPLC-MS/MS (white bars) and HPLC/FD (black bars);
- Each bar represents the mean and standard deviation of 10 samples.
- Figure 2 shows sample mass chromato grams of free amino acids in
- FIG. 1 shows the fold increase over wild type in seed amino acid content for 43 mutants affected in the production of Asp-derived amino acids. Each bar represents the average of 3 to 8 mutant measurements compared to the average amino acid content of 7 to 24 wild type plants that were grown together and assayed by HPLC-MS/MS in the same microtiter plate. Error bars represent the standard error of the difference of the mutant and wild type means for each line.
- FIG. 4 shows correlation of seed Ile and Leu contents of Col-0, Ler, and mutants. Mutant data points are the average of 3 to 8 measurements; wild-type Col-0 and Ler the average of 32 measurements. Mutants are the same as the Ile + Leu mutants in Figure 4.
- Figure 5 shows distribution of seed Thr content in segregating F 2 lines derived from a cross between mutant line HST2 and wild-type Ler. Bars representing seed Thr content of four Col-0 and four Ler plants are indicated on the right. The Y— axis scale represents Thr peak areas divided by the peak area of a Val-d8 standard added to each sample.
- FIG. 6 shows that cloned Arabidopsis Thr aldolase relieves the Gly auxotrophy of yeast strain YM13.
- the top half of each plate is the W3031 B wild-type GLY1; SHM1; SHM2 haploid strain; the bottom half is the isogenic Gly auxotroph strain YM13 glyl; shml; shm2.
- Figure 7 shows pathways and locations of enzymes involved in photorespfration. If threonine aldolase were expressed in the mitochondria (it is normally in the cytosol), some of the glycine that is converted to serine by serine hydroxymethyltransferase would be converted to threonine.
- Figure 8 shows the pathway leading to isoleucine, leucine, and valine from threonine pyruvate, including sited of feedback inhibition.
- TD threonine deaminase
- ALS acetolactate synthase.
- Increased threonine levels are a prerequisite for having increased isoleucine levels in the plant.
- Increased production of threonine through manipulation of threonine aldolase could be combined with downstream enzymes to increase isoleucine content.
- Figure 9 shows biosynthetic pathways leading from aspartate to threonine, methionine, lysine, and isoleucine, including known mechanisms of feedback inhibition.
- AK aspartate kinase
- DHDPS dihydrodipicolinate synthase
- HSD homeserine dehydrogenase
- TS threonine synthase
- TD threonine deaminase
- LKR lysine ketoglutarate reductase
- SAMS s-adenosylmethionine synthase
- ALS acetolactate synthase
- CGS cystathionine gamma-synthase.
- the present invention relates to a nucleic acid construct having a nucleic acid molecule configured to silence threonine aldolase expression.
- the construct also includes a 5' DNA promoter sequence and a 3' terminator sequence.
- the nucleic acid molecule, the promoter, and the terminator are operatively coupled to permit transcription of the nucleic acid molecule.
- a suitable nucleic acid molecule configured to silence threonine aldolase expression can include, for example, any nucleic acid molecule that silences expression of any threonine aldolase in a plant. Examples of threonine aldolases from various plants are described below. [0034] One example of a threonine aldolase is from Arabidopsis thaliana
- This Arabidopsis thaliana threonine aldolase has an amino acid sequence of SEQ ID NO:l (GenBank gi] 18390920) as follows: 1 MVMRSVDLRS DTVTRPTDAM REAMCNAEVD DDV GYDPTA RRLEE ⁇ MAKM 51 MGKEAA FVP SGTMGNLISV MVHCDVRGSE VILGDNCHIH VYENGGISTI 101 GGVHPKTVKN EEDGTMDLEA IEAAIRDPKG STFYPSTRLI CLENTHANSG
- This protein is encoded by a gene found on chromosome 1 of Arabidopsis thaliana and has a nucleotide sequence of SEQ ID NO:2 (GenBank gi
- This protein is encoded by a gene found on chromosome 3 of Arabidopsis thaliana and has a nucleotide sequence of SEQ ID NO: 4 (GenBank gi
- a tlireonine aldolase from rice (Oiyza sativ ) has an amino acid sequence of SEQ ID NO:5 (GenBank gi
- This protein is encodedby a gene having the nucleotide sequence ofSEQ ID NO:6 (GenBank gi
- a threonine aldolase from corn has an amino acid sequence ofSEQ IDNO:7 (based uponthe Open Reading Frame Finder (GenBank, NIH) graphical analysis ofGenBank gi
- GLKEVKGLRVDAGSVETNMVFIDIEEGTKTRAEKICKYMEERGILVMQESSSRMRW LHHQISASDVQYALSCFQALAVKGVQNEMG This protein is encoded by a gene having the nucleotide sequence of SEQ ID NO:8 (GenBank gi
- the threonine aldolase from soybean has an amino acid sequence of SEQ ID NO:9 (GenBank gi
- MVTRIVDLRSDTVTKPTEAMRAAMASAEVDDDV GYDPTAFRLETEMAKTMGKEAAL FVPSGTMGNLVSVLVHCDVRGSEVI GDNCHINIFENGGIATIGGVHPRQVKNNDDG TMDIDLIEAAIRDPMGELFYPTTKLICLENTHANSGGRCLSVEYTDRVGELAKKHGL KLHIDGARIFNASVALGVPVDRLVQAADSVSVCLSKGIGAPVGSVIVGSKNFIAKAR RLRKTLGGGMRQIGLLCAAALVALQENVGKLESDHKKARL ADGLNEVKGLRVDACS VETNMVFIDIEEGTKTRAEKICKYMEERGI VMQESSSRMRWLHHQISASDVQYAL SCFQQALAVKGVQKEMGN
- This protein is encoded by a gene having the nucleotide sequence of SEQ ID NO: 10 (GenBank gi
- This protein is encoded by a gene having the nucleotide sequence of SEQ ID NO: 12 (GenBank g ⁇
- This protein is encoded by a gene having the nucleotide sequence of SEQ ID NO: 14 (GenBank gi
- a threonine aldolase from cotton has an amino acid sequence of SEQ ID NO: 17 (based on the Open Reading Frame Finder (GenBank, NIH) graphical anaylsis of GenBank gi
- This protein is encoded by a gene having the nucleotide sequence of SEQ ID NO: 18 (GenBank gi
- the nucleic acid molecule configured to silence threonine aldolase is effective in silencing expression of a threonine aldolase polypeptide having an amino acid sequence that is at least 70 percent identical (or alternatively 75 percent, 80 percent, 85 percent, 90 percent, or 95 percent identical) to a threonine aldolase amino acid sequence of, for example, SEQ ID NO:l, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:ll, SEQ ID NO: 13, SEQ ID NO: 15, and/or SEQ ID NO: 17.
- the nucleic acid molecule configured to silence threonine aldolase is effective in silencing expression of a trrreonine aldolase polypeptide having an amino acid sequence that is at least 70 percent identical (or alternatively 75 percent, 80 percent, 85 percent, 90 percent, or 95 percent identical) to at least 100 amino acid residues of a threonine aldolase amino acid sequence of, for example, SEQ ID NO:l, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:ll, SEQ ID NO:13, SEQ ID NO:15, and/or SEQ ID NO: 17.
- the nucleic acid molecule configured to silence tlireonine aldolase is effective in silencing expression of a threonine aldolase that is encoded by an encoding nucleic acid molecule having a nucleotide sequence that is at least 70 percent identical (or alternatively 75 percent, 80 percent, 85 percent, 90 percent, or 95 percent identical) to a nucleotide sequence of, for example, SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO:12, SEQ ID NO:14, SEQ ID NO:16, and/or SEQ ID NO:18.
- the nucleic acid molecule configured to silence threonine aldolase is effective in silencing expression of a threonine aldolase polypeptide that is encoded by an encoding nucleic acid molecule having a nucleotide sequence that is at least 70 percent identical (or alternatively 75 percent, 80 percent, 85 percent, 90 percent, or 95 percent identical) to at least 300 nucleotide bases of a nucleotide sequence of, for example, SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO:14, SEQ ID NO:16, and/or SEQ ID NO:18.
- the nucleic acid construct of the present invention can include a nucleic acid molecule that includes a dominant negative mutation and encodes a non- functional threonine aldolase. This construct is suitable in suppression or interference of endogenous mRNA encoding threonine aldolase.
- the nucleic acid construct of the present invention can include a nucleic acid molecule that is positioned in the nucleic acid construct to result in suppression or interference of endogenous mRNA encoding threonine aldolase.
- the nucleic acid construct of the present invention can include a nucleic acid molecule that encodes threonine aldolase and is in sense orientation.
- the nucleic acid construct of the present invention can include a nucleic acid molecule that is an antisense form of a threonine aldolase encoding nucleic acid molecule.
- the nucleic acid construct of the present invention can include a nucleic acid molecule including a first segment encoding a threonine aldolase, a second segment in an antisense form of a threonine aldolase encoding nucleic acid molecule, and a third segment linking the first and second segments.
- the DNA promoter of the nucleic acid construct of the present invention can include, for example, a constitutive plant promoter or an inducible plant promoter.
- the DNA promoter of the nucleic acid construct of the present invention can be, for example, a tissue-specific promoter and/or an organ- specific promoter.
- the present invention further relates to expression vectors, host cells, plant cells, plants, and plant seeds having a nucleic acid molecule configured to silence threonine aldolase expression.
- the present invention further relates to animal feed and foodstuff containing the plant seeds having the nucleic acid molecule configured to silence threonine aldolase expression.
- Another aspect of the present invention is a method of increasing threonine content in a plant. This method involves providing a transgenic plant or plant seed transformed with a nucleic acid construct having a nucleic acid molecule configured to silence threonine aldolase expression, a 5' DNA promoter sequence, and a 3' terminator sequence. The method involves growing the transgenic plant or a transgenic plant grown from the transgenic plant seed under conditions effective to increase the threonine content of the transgenic plant or the plant grown from the transgenic plant seed.
- the transgenic plant or transgenic plant grown from the transgenic plant seed is obtained by providing a nucleic acid construct having a nucleic acid molecule configured to silence threonine aldolase expression (examples of which are described herein), a 5' DNA promoter sequence; and a 3' terrninator sequence, where the nucleic acid molecule, the promoter, and the terminator are operatively coupled to permit transcription of the nucleic acid molecule.
- a plant cell is then transformed with the nucleic acid construct to yield a transgenic plant with increased threonine content (compared to a non-transgenic plant).
- the method can further involve propagating plants from the transformed plant cell.
- Suitable methods for fransforrning the plant can include, for example, Agrobacterium-mGdiated transformation, vacuum infiltration, biolistic transformation, electroporation, micro-injection, polyethylene-mediated transformation, and/or laser- beam transformation. The various aspects of this method are described in more detail infra.
- the nucleic acid construct results in interference of tlireonine aldolase expression by sense or co-suppression in which the nucleic acid molecule of the construct is in a sense (5'- 3') orientation.
- Co- suppression has been observed and reported in many plant species and may be subject to a transgene dosage effect or, in another model, an interaction of endogenous and transgene transcripts that results in aberrant mRNAs (Senior, "Uses of Plant Gene Silencing,” Biotechnology and Genetic Engineering Reviews 15:79-119 (1998); Waterhouse et al., "Exploring Plant Genomes by RNA-Induced Gene Silencing,” Nature Review: Genetics 4: 29-38 (2003), which are hereby incorporated by reference in their entirety).
- a construct with the nucleic acid molecule in the sense orientation may also give sequence specificity to RNA silencing when inserted into a vector along with, a construct of both sense and antisense nucleic acid orientations as described infra (Wesley et al., "Construct Design for Efficient, Effective and High- Throughput Gene Silencing in Plants,” Plant Journal 27(6) 581-590 (2001), which is hereby incorporated by reference in its entirety).
- the nucleic acid construct results in interference of threonine aldolase expression by the use of antisense suppression in which the nucleic acid molecule of the construct is an antisense (3' ⁇ 5') orientation.
- antisense RNA to down-regulate the expression of specific plant genes is well known (van der Krol et al., Nature, 333:866- 869 (1988) and Smith et al., Nature, 334:724-726 (1988), which are hereby incorporated by reference in their entirety).
- Antisense nucleic acids are DNA or RNA molecules that are complementary to at least a portion of a specific mRNA molecule (Weintraub, "Antisense RNA and DNA,” Scientific American 262:40 (1990), which is hereby incorporated by reference in its entirety). In the target cell, the antisense nucleic acids hybridize to a target nucleic acid and interfere with transcription, and/or RNA processing, transport, translation, and/or stability.
- one aspect of the present invention involves a construct which contains the nucleic acid molecule of the present invention being inserted into the construct in antisense orientation.
- Interference of threonine aldolase expression is also achieved in the present invention by the generation of double-stranded RNA ("dsRNA") through the use of inverted-repeats, segments of gene-specific sequences oriented in both sense and antisense orientations.
- sequences in the sense and antisense orientations are linked by a tliird segment, and inserted into a suitable expression vector having the appropriate 5' and 3' regulatory nucleotide sequences operably linked for transcription.
- the expression vector having the modified nucleic acid molecule is then inserted into a suitable host cell or subject.
- the third segment linking the two segments of sense and antisense orientation may be any nucleotide sequence such as a fragment of the ⁇ - glucuronidase ("GUS”) gene.
- a functional (splicing) intron of tlireomne aldolase may be used for the third (linking) segment, or, in yet another aspect of the present invention, other nucleotide sequences without complementary components in the threonine aldolase gene may be used to link the two segments of sense and antisense orientation (Chuang et al., "Specific and Heritable Genetic Interference by Double- Stranded RNA in Arabidopsis thaliana," Proc.
- the sense and antisense segments may be oriented either head-to-head or tail-to-tail in the construct.
- hpRNA hairpin RNA
- dsRNA hairpin RNA
- Another aspect of the present invention involves using hairpin RNA (“hpRNA”) which may also be characterized as dsRNA. This involves RNA hybridizing with itself to form a hairpin structure that comprises a single-stranded loop region and a base-paired stem.
- a linker may be used between the inverted repeat segments of sense and antisense sequences to generate hairpin or double-stranded RNA, the use of intron- free hpRNA can also be used to achieve silencing of tlireonine aldolase expression.
- a plant may be transformed with constructs encoding both sense and antisense orientation molecules having separate promoters and no third segment linking the sense and antisense sequences (Chuang et al., "Specific and Heritable Genetic Interference by Double-Stranded RNA in Arabidopsis thaliana," Proc.
- tlireonine aldolase nucleotide sequences of the present invention may be inserted into any of the many available expression vectors and cell systems using reagents that are well known in the art.
- Suitable vectors include, but are not limited to, the following viral vectors such as lambda vector system gtl 1, gt WES.tB, Charon 4, and plasmid vectors such as pG-Cha, p35S-Cha, pBR322, pBR325, pACYC177, pACYC1084, pUC8, pUC9, pUC18, pUC19, pLG339, pR290, pKC37, pKClOl, SV 40, pBluescript II SK+/- or KS +/- (see "Stratagene Cloning Systems” Catalog (1993) from Stratagene, La Jolla, CA, which is hereby incorporated by reference in its entirety), pQE, pIH821, pGEX, pET series (see Studier et. al., "Use of T7 RNA Polymerase to Direct Expression of Cloned Genes," Gene Expression
- viral vectors such as lamb
- Recombinant molecules can be introduced into cells via transformation, particularly transduction, conjugation, mobilization, or electroporation.
- the DNA sequences are cloned into the vector using standard cloning procedures in the art, as described by Sambrook et al., Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor, NY:Cold Spring Harbor Press (1989), and Ausubel et al., Current Protocols in Molecular Biology, New York, N.Y:John Wiley & Sons (1989), which are hereby incorporated by reference in their entirety.
- the various nucleic acid sequences may normally be inserted or substituted into a bacterial plasmid.
- Any convenient plasmid may be employed, which will be characterized by having a bacterial replication system, a marker which allows for selection in a bacterium, and generally one or more unique, conveniently located restriction sites.
- Numerous plasmids referred to as transformation vectors, are available for plant transformation. The selection of a vector will depend on the preferred transformation technique and target species for transformation. A variety of vectors are available for stable transformation using Agrobacterium tumefaciens, a soilborne bacterium that causes crown gall.
- Crown gall are characterized by tumors or galls that develop on the lower stem and main roots of the infected plant. These tumors are due to the transfer and incorporation of part of the bacterium plasmid DNA into the plant chromosomal DNA.
- This transfer DNA (T-DNA) is expressed along with the normal genes of the plant cell.
- the plasmid DNA, pTi, or Ti-DNA, for "tumor inducing plasmid,” contains the vir genes necessary for movement of the T-DNA into the plant.
- the T- DNA carries genes that encode proteins involved in the biosynthesis of plant regulatory factors, and bacterial nutrients (opines).
- the T-DNA is delimited by two 25 bp imperfect direct repeat sequences called the "border sequences.”
- the border sequences By removing the oncogene and opine genes, and replacing them with a gene of interest, it is possible to transfer foreign DNA into the plant without the formation of tumors or the multiplication oi Agrobacterium tumefaciens. Fraley et al., "Expression of Bacterial Genes in Plant Cells," Proc. Nat'l Acad. Sci. 80:4803-4807 (1983), which is hereby incorporated by reference in its entirety. [0060] Further improvement of this technique led to the development of the binary vector system. Bevan, "Binary Agrobacterium Vectors for Plant Transformation,” Nucleic Acids Res.
- control elements or "regulatory sequences” are also incorporated into the vector-constmct. These include non-translated regions of the vector, promoters, and 5' and 3' untranslated regions which interact with host cellular proteins to carry out transcription and translation. Such elements may vary in their strength and specificity. Depending on the vector system and host utilized, any number of suitable transcription and translation elements, including constitutive and inducible promoters, may be used. Tissue-specific and organ-specific promoters can also be used.
- a constitutive promoter is a promoter that directs expression of a gene throughout the development and life of an organism.
- Examples of some constitutive promoters that are widely used for inducing expression of transgenes include the nopaline synthase (NOS) gene promoter, from Agrobacterium tumefaciens (U.S. Patent No. 5,034,322 to Rogers et al., which is hereby incorporated by reference in its entirety), the cauliflower mosaic virus (CaMV) 35S and 19S promoters (U.S. Patent No.
- An inducible promoter is a promoter that is capable of directly or indirectly activating transcription of one or more DNA sequences or genes in response to an inducer. In the absence of an inducer, the DNA sequences or genes will not be transcribed.
- the inducer can be a chemical agent, such as a metabolite, growth regulator, herbicide, or phenolic compound, or a physiological stress directly imposed upon the plant such as cold, heat, salt, toxins, or through the action of a pathogen or disease agent such as a virus or fungus.
- a plant cell containing an inducible promoter may be exposed to an inducer by externally applying the inducer to the cell or plant such as by spraying, watering, heating, or by exposure to the operative pathogen.
- An example of an appropriate inducible promoter is a glucocorticoid-inducible promoter (Schena et al., "A Steroid-Inducible Gene Expression System for Plant Cells," Proc. Natl. Acad. Sci.
- transgene-encoded protein is induced in the transformed plants when the transgenic plants are brought into contact with nanomolar concentrations of a glucocorticoid, or by contact with dexamethasone, a glucocorticoid analog.
- Scbena et al. "A Steroid-Inducible Gene Expression System for Plant Cells," Proc. Natl. Acad. Sci. USA 88:10421-5 (1991); Aoyama et al., "A Glucocorticoid-Mediated Transcriptional Induction System in Transgenic Plants," Plant J.
- inducible promoters include promoters that function in a tissue specific manner to regulate the gene of interest within selected tissues of the plant. Examples of such tissue specific or developmentally regulated promoters include seed, flower, fruit, or root specific promoters as are well known in the field (U.S. Patent No. 5,750,385 to Shewmaker et al., which is hereby incorporated by reference in its entirety).
- tissue specific or developmentally regulated promoters include seed, flower, fruit, or root specific promoters as are well known in the field (U.S. Patent No. 5,750,385 to Shewmaker et al., which is hereby incorporated by reference in its entirety).
- One of the promoters suitable in the present invention is the tuber-specific granule bound starch synthase (GBSS) promoter.
- tissue- and organ-specific promoters have been developed for use in genetic engineering of plants (Potenza et al., “Targeting Transgene Expression in Research, Agricultural, and Environmental Applications: Promoters used in Plant Transformation," In Vitro Cell. Dev. Biol. Plant 40:1-22 (2004), which is hereby incorporated by reference in its entirety).
- promoters include those that are floral-specific (Annadana et al., "Cloning of the Chrysanthemum UEP1 Promoter and Comparative Expression in Florets and Leaves of Dendranthema grandiflora " Transgenic Res.
- the nucleic acid construct of the present invention also includes an operable 3' regulatory region, selected from among those which are capable of providing correct transcription termination and polyadenylation of mRNA for expression in the host cell of choice, operably linked to a modified trait nucleic acid molecule of the present invention.
- operable 3' regulatory region selected from among those which are capable of providing correct transcription termination and polyadenylation of mRNA for expression in the host cell of choice, operably linked to a modified trait nucleic acid molecule of the present invention.
- 3' regulatory regions are known to be operable in plants. Exemplary 3' regulatory regions include, without limitation, the nopaline synthase ("nos") 3' regulatory region (Fraley et al., "Expression of Bacterial Genes in Plant Cells," Proc. Nat 'I Acad. Sci.
- nucleic acid constructs of the present invention can be ligated together to produce the expression systems which contain the nucleic acid constructs of the present invention, using well known molecular cloning techniques as described in Sambrook et al., Molecular Cloning: A Laboratory Manual, Second Edition Cold Spring Harbor, NY:Cold Spring Harbor Press (1989), and Ausubel et al. Current Protocols in Molecular Biology, New York, N.Y:John Wiley & Sons (1989), which are hereby incorporated by reference in their entirety. [0068] Once the nucleic acid construct of the present invention has been prepared, it is ready to be incorporated into a host cell.
- another aspect of the present invention relates to a recombinant host cell containing one or more of the nucleic acid constructs.
- this method is carried out by transforuiing a host cell with a nucleic acid construct of the present invention under conditions effective to achieve transcription of the nucleic acid molecule in the host cell.
- This is achieved with standard cloning procedures known in the art, such as described by Sambrook et al., Molecular Cloning: A Laboratory Manual, Second Edition, Cold Springs Laboratory, Cold Springs Harbor, New York (1989), which is hereby incorporated by reference in its entirety.
- Suitable host cells include, but are not limited to, bacteria, virus, yeast, mammalian cells, insect, plant, and the like.
- the host cells are either a bacterial cell or a plant cell.
- Methods of transformation may result in transient or stable expression of the nucleic acid under control of the promoter.
- a nucleic acid construct of the present invention is stably inserted into the genome of the recombinant plant cell as a result of the transformation, although transient expression can serve an important purpose, particularly when the plant under investigation is slow-growing.
- Plant tissue suitable for transformation includes leaf tissue, root tissue, meristems, zygotic and somatic embryos, callus, protoplasts, tassels, pollen, embryos, anthers, and the like. The means of transformation chosen is that most suited to the tissue to be transformed.
- Transient expression in plant tissue can be achieved by particle bombardment (Klein et al., "High- Velocity Microprojectiles for Delivering Nucleic Acids Into Living Cells," Nature 327:70-73 (1987), which is hereby incorporated by reference in its entirety), also known as biolistic transformation of the host cell, as disclosed in U.S. Patent Nos.
- Biologically active particles e.g., dried bacterial cells containing the vector and heterologous DNA
- Other variations of particle bombardment now known or hereafter developed, can also be used.
- An appropriate method of stably introducing the nucleic acid construct into plant cells is to infect a plant cell with Agrobacterium tumefaciens or Agrobacterium rhizogenes previously transformed with the nucleic acid construct.
- the Ti (or RI) plasmid of Agrobacterium enables the highly successful transfer of a foreign nucleic acid molecule into plant cells.
- a variation of Agrobacterium transformation uses vacuum infiltration in which whole plants are used (Senior, "Uses of Plant Gene Silencing," Biotechnology and Genetic Engineering Reviews 15:79-119 (1998), which is hereby incorporated by reference in its entirety).
- nucleic acid molecule may also be introduced into the plant cells by electroporation (Fromm et al., Proc. Natl. Acad. Sci. USA 82:5824 (1985), which is hereby incorporated by reference in its entirety).
- plant protoplasts are electroporated in the presence of plasmids containing the expression cassette.
- Electroporated plant protoplasts reform the cell wall, divide, and regenerate.
- Other methods of transformation include polyethylene-mediated plant transformation, micro-injection, physical abrasives, and laser beams (Senior, "Uses of Plant Gene Silencing," Biotechnology and Genetic Engineering Reviews 15:79-119 (1998), which is hereby incorporated by reference in its entirety).
- the precise method of transformation is not critical to the practice of the present invention. Any method that results in efficient transformation of the host cell of choice is appropriate for practicing the present invention. [0074] After transformation, the transformed plant cells must be regenerated.
- Means for regeneration vary from species to species of plants, but generally a suspension of transformed protoplasts or a petri plate containing explants is first provided. Callus tissue is formed and shoots may be induced from callus and subsequently rooted. Alternatively, embryo formation can be induced in the callus tissue. These embryos germinate as natural embryos to form plants.
- the culture media will generally contain various amino acids and hormones, such as auxin and cytokinins. Efficient regeneration will depend on the medium, on the genotype, and on the history of the culture. If these three variables are controlled, then regeneration is usually reproducible and repeatable.
- transformed cells are first identified using a selection marker simultaneously introduced into the host cells along with the nucleic acid construct of the present invention.
- selection markers include, without limitation, markers encoding for antibiotic resistance, such as the neomycin phosphotransferae II ("nptll") gene which confers kanamycin resistance (Fraley et al., Proc. Natl. Acad. Sci. USA 80:4803-4807 (1983), which is hereby incorporated by reference in its entirety), and the genes which confer resistance to gentamycin, G418, hygromycin, streptomycin, spectinomycin, tetracycline, chloramphenicol, and the like.
- nptll neomycin phosphotransferae II
- Cells or tissues are grown on a selection medium containing the appropriate antibiotic, whereby generally only those transformants expressing the antibiotic resistance marker continue to grow.
- Other types of markers are also suitable for inclusion in the expression cassette of the present invention.
- a gene encoding for herbicide tolerance such as tolerance to sulfonylurea is useful, or the dhfr gene, which confers resistance to metriotrexate (Bourouis et al., EMBO J. 2: 1099- 1104 (1983), which is hereby incorporated by reference in its entirety).
- reporter genes which encode for enzymes providing for production of an identifiable compound are suitable.
- uidA a gene from Escherichia coli that encodes the ⁇ -glucuronidase protein, also known as GTJS (Jefferson et al., "GUS Fusions: ⁇ Glucuronidase as a Sensitive and Versatile Gene Fusion Marker in Higher Plants," EMBO J. 6:3901-3907 (1987), which is hereby incorporated by reference in its entirety).
- GTJS ⁇ -glucuronidase protein
- enzymes providing for production of a compound identifiable by luminescence, such as luciferase, are useful.
- the selection marker employed will depend on the target species; for certain target species, different antibiotics, herbicide, or biosynthesis selection markers are preferred.
- transgenic plants Plant cells and tissues selected by means of an inhibitory agent or other selection marker are then tested for the acquisition of the transgene (Sambrook et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, New Yori Cold Spring Harbor Press (1989), which is hereby incorporated by reference in its entirety).
- the transgene can be transferred to other plants by sexual crossing. Any of a number of standard breeding techniques can be used, depending upon the species to be crossed.
- transgenic plants of this type are produced, the plants themselves can be cultivated in accordance with conventional procedure so that the nucleic acid construct is present in the resulting plants.
- transgenic seeds are recovered from the transgenic plants. These seeds can then be planted in the soil and cultivated using conventional procedures to produce transgenic plants. The component parts and fruit of such plants are encompassed by the present invention.
- the present invention can be utilized in conjunction with a wide variety of plants or their seeds. Suitable plants are any plant with a threonine aldolase gene, including dicots and monocots. Plants can include: rice, corn, soybean, canola, potato, wheat, mung bean, alfalfa, barley, rye, cotton, sunflower, peanut, sweet potato, bean, pea, chicory, lettuce, endive, cabbage, bmssel sprout, beet, parsnip, turnip, cauliflower, broccoli, radish, spinach, onion, garlic, eggplant, pepper, celery, carrot, squash, pumpkin, zucchini, cucumber, apple, pear, melon, citrus, strawberry, grape, raspberry, pineapple, tobacco, tomato, sorghum, sugarcane, banana, Arabidopsis thaliana, Saintpaulia, petunia, pelargonium, poinsettia, chrysanthemum, carnation, and zinnia.
- the present invention also relates to expression vectors, host cells, plant cells, plants, and plant seeds having a nucleic acid molecule configured to silence threonine aldolase expression.
- the present invention further relates to animal feed and foodstuff containing the plant seeds having the nucleic acid molecule configured to silence tlireonine aldolase expression.
- the present invention also relates to a method of making a mutant plant having an increased level of seed threonine compared to that of a non-mutant plant.
- This method involves providing at least one cell of a non-mutant plant containing a gene encoding a functional threonine aldolase.
- the at least one cell of a non-mutant plant is treated under conditions effective to inactivate the gene, thereby yielding at least one mutant plant cell containing an inactivated tlireonine aldolase gene.
- the at least one mutant plant cell is propagated into a mutant plant, which has an increased level of seed tlireonine compared to that of the non-mutant plant.
- the functional threonine aldolase can be as described herein supra.
- the treating step inolves subjecting the at least one cell of the non-mutant plant to a chemical mutagenizing agent under conditions effective to yield at least one mutant plant cell contarning an inactive tfaeonine aldolase gene.
- Suitable chemical mutagenizing agents can include, for example, ethylmethanesulfonate.
- the treating step inolves subjecting the at least one cell of the non-mutant plant to a radiation source under conditions effective to yield at least one mutant plant cell contarning an inactive threonine aldolase gene.
- Suitable radiation sources can include, for example, sources that are effective in producing ultraviolet rays, gamma rays, or fast neutrons.
- the treating step inolves inserting an inactivating nucleic acid molecule into the gene encoding the functional threonine aldolase or its promoter under conditions effective to inactivate the gene.
- Suitable deactivating nucleic acid molecules can include, for example, a transposable element.
- transpo sable elements include, without limitation, an Activator (Ac) transposon, a Dissociator (Ds) transposon, or a Mutator (Mu) transposon.
- Ac Activator
- Ds Dissociator
- Mo Mutator
- the treating step involves subjecting the at least one cell of the non-mutant plant to Agrobacterium transformation under conditions effective to insert an Agrobacterium T-DNA sequence into the gene, thereby inactivating the gene.
- Suitable Agrobacterium T-DNA sequences can include, for example, those sequences that are carried on a binary transformation vector of AC 106, pAC161, pGABIl, pADISl, pCSAHO, pDAPlOl, derivatives ofpBLN19, or pCAMBIA plasmid series.
- the treating step inolves transforming the at least one cell of the non-mutant plant by site- directed mutagenesis of the threonine aldolase gene or its promoter under conditions effective to yield at least one mutant plant cell containing an inactive threonine aldolase gene.
- the treating step can also involve mutagenesis by homologous recombination of the threonine aldolase gene or its promoter, targeted deletion of a portion of the threonine aldolase gene sequence or its promoter, and/or targeted insertion of a nucleic acid sequence into the tlireonine aldolase gene or its promoter.
- the various plants that can be used in this method are the same as those described supra with respect to the method of increasing threonine content in a plant.
- Another aspect of the present invention relates to mutant plants produced by this method, as well as mutant plant seeds produced by growing the mutant plant under conditions effective to cause the mutant plant to produce seed.
- the present invention further relates to a nucleic acid construct having a nucleic acid molecule encoding a tlireonine aldolase.
- the construct also includes a mitochondrial targeting sequence, a 5' DNA promoter sequence, and a 3' terminator sequence.
- the nucleic acid molecule encoding a tlireonine aldolase, the mitochondrial targeting sequence, the promoter, and the terminator are operatively coupled to permit transcription of the nucleic acid molecule.
- Suitable nucleic acid molecules encoding threonine aldolases include, for example, those described herein supra.
- Suitable mitochondrial targeting sequences can be mitochondrial targeting leader sequences including, for example, a soybean alternative oxidase gene (GenBank gi
- the DNA promoter (of the nucleic acid constmct containing the nucleic acid molecule encoding a threoriine aldolase) can include, for example, a constitutive plant promoter or an inducible plant promoter (as described in more detail supra).
- the DNA promoter of this nucleic acid constmct can be, for example, a tissue- specific promoter (as described in more detail supra).
- the present invention further relates to expression vectors, host cells, plant cells, plants, and plant seeds having a nucleic acid constmct including a nucleic acid molecule encoding a threonine aldolase, a mitochondrial targeting sequence, a 5' DNA promoter sequence, and a 3' terminator sequence.
- the present invention further relates to arrimal feed and foodstuff containing the plant seeds having this nucleic acid construct.
- Another aspect of the present invention is a method of increasing threonine content in a plant by providing a transgenic plant or plant seed transformed with a nucleic acid construct having a nucleic acid molecule encoding a threonine aldolase, a mitochondrial targeting sequence, a 5' DNA promoter sequence, and a 3' terminator sequence.
- the method involves growing the transgenic plant or a transgenic plant grown from the transgenic plant seed under conditions effective to increase the tlireonine content of the transgenic plant or the plant grown from the transgenic plant seed.
- the step of providing a transgenic plant or plant seed transformed with the nucleic acid construct involves providing the constmct and transforming a plant cell with the construct.
- Suitable methods for transforming the plant can include, for example, Agrobacterium-med ⁇ ated transformation, vacuum infiltration, biolistic transformation, electroporation, micro- injection, polyethylene-mediated transformation, and/or laser-beam transformation.
- the present invention also relates to a method of increasing isoleucine content in a plant. This method involves providing a non-wild-type plant having increased threonine content compared to a corresponding wild-type plant.
- the non- wild-type plant is transformed with a nucleic acid construct under conditions effective to yield a transgenic plant that overexpresses an enzyme that functions to catalyze biosynthesis of isoleucine from threoriine.
- the nucleic acid construct used for this method includes a nucleic acid molecule including an enzyme that functions to catalyze biosynthesis of isoleucine from threonine, a 5' DNA promoter sequence, and a 3' terminator sequence.
- the nucleic acid molecule, the promoter, and the terminator are operatively coupled to permit transcription of the nucleic acid molecule.
- the method involves growing the transgenic plant under conditions effective to increase the isoleucine content of the transgenic plant.
- Suitable enzymes for use in this method include, for example, threonine deaminase and acetolactate synthase.
- non- feedback-inhibited forms of the threonine deaminase or acetolactate synthase can be used.
- the non-wild-type plant is a mutant plant containing a gene encoding a nonfunctional threonine aldolase.
- the non-wild-type plant is a plant transformed with a tfreonine aldolase silencing nucleic acid constmct.
- a suitable threonine aldolase silencing nucleic acid constmct can include a nucleic acid molecule configured to silence threonine aldolase expression, a 5' DNA promoter sequence, and a 3' terminator sequence, where the nucleic acid molecule, the promoter, and the terminator are operatively coupled to permit transcription of the nucleic acid molecule. Examples of these threonine silencing nucleic acid constructs are described herein supra.
- the present invention also relates to a method of identifying a plant having a high seed threonine content.
- This method involves providing a candidate plant.
- the candidate plant is analyzed for the presence, in its genome, of a gene encoding a non- functional threonine aldolase. The presence of the gene indicates that the candidate plant has high seed tlireonine content.
- Example 1 Application of a High-Throughput HPLC-MS/MS Assay to Arabidopsis Mutant Screening; Evidence That Threonine Aldolase Plays a Role in Seed Nutritional Quality
- Map-based cloning demonstrated that one mutant has increased seed Thr content due to a mutation in Thr aldolase.
- the methodology described below will allow similar mutant screens to be performed in other genetically tractable plants, and direct monitoring of nutritionally valuable molecules in conventional and molecular plant breeding.
- Col-0, Ler and RI lines were obtained from the Arabidopsis Biological Resource Center (www.arabidopsis.org). Mutagenized Col-0 and Ler seeds were purchased from Lehle Seeds (Round Rock, TX). Generation of mutant populations has been described previously (Van Eenennaam et al., "Engineering Vitamin E Content: From Arabidopsis Mutant to Soy Oil," Plant Cell 15:3007-3019 (2003), which is hereby incorporated by reference in its entirety).
- Plants were grown in Conviron (Winnipeg, Canada) growth chambers in standard nursery flats (approximately 20 cm by 40 cm) using Metromix 200 potting soil (Scotts, Marysville, OH) at 23 °C under continuous cool white fluorescent light with an intensity of 150 micromols m "2 sec "1 photo synthetic photon flux density (PPFD). Plants were fertilized twice weekly with a dilute solution of Peters 20-20-20 fertilizer (Scotts, Marysville, OH), adjusted to a 50 ppm nitrogen concentration. A maximum of 96 M 2 lines were planted from each of 110 independent seed pools. Since each pool contained an average of 8 seeds from each of 1000 Mi lines, the chances of planting sibling M 2 seeds were low.
- PPFD photo synthetic photon flux density
- YM13 W3031B shml::HIS3 shm2::LEU2 glyl::URA3 were kindly supplied by A. Bognar (Univerity of Toronto).
- Yeast strains were grown on YPD medium (1% yeast extract, 2% peptone, 2% dextrose) or on SD medium (0.67% Bacto-yeast nitrogen bas, 2% dextrose) supplemented, where appropriate, with 750 ⁇ g/ml Gly, 30 ⁇ g/ml Leu, and 20 ⁇ g ml each uracil, Trp, adenine, and His.
- 2,3,4,4,4,5,5,5-d8 (Aldrich) was added to each tube and samples were reconstituted by letting them dissolve at for 30 min at 4°C.
- approximately 100 mg of Arabidopsis leaf material was placed into 1.4 ml tubes in a 96-well microtiter plate (Matrix). The tissue was frozen in liquid nitrogen and lyophilized, resulting in approximately 10 mg of dried leaf material. Further processing of these samples was the same as described above for Arabidopsis seeds.
- the sample injection volume was 5 ⁇ l, and a Gilson (Middleton, WI) 215 liquid handler equipped with an 819 injector was used to load the samples.
- Mobile phases used were A. 0.05% acetic acid in water and B. 90% acetonitrile, 0.05% acetic acid in water.
- the total HPLC run time was 1.5 min, using the following gradient: 0 to 0.6 min 100% A, 1 nil/min; 0.61 to 1.0 min, 90% B, 1 to 3 ml/min; 1.1 to 1.4 min, 100% A, 3 ml min, 1.4 to 1.5 min, 100% A, 3 to 1 nil/min.
- Amino acids were detected using a Micromass Triple Quadrupole Quattro Ultima mass spectrometer (Waters, Milford, MA) using an electro spray positive mode, 3.0 kV capillary voltage, 25 V cone voltage, 120°C source temperature, and 300°C desolvation temperature. Collection times, collision energies and masses of observed ions for each amino acid were as described in Table 1. Table 1. Collection times, collision energy and masses of observed ions
- Example 6 Ile/Leu Separation Method
- the instmmentation described above for the 19 amino acid separation was used, but the HPLC-MS/MS protocol was changed. Mobile phases were: A. 0.05% acetic acid in water and B. 100% acetonitrile, 0.05% acetic acid.
- the total HPLC run time was 4 min using the following gradient: 0 to 2 min, 100% A, 1.5 niFmin; 2 to 3 min, 10% A, 90% B, 1.5 ml/min; 3 to 4 min, 100% A, 2 ml/min.
- Ile and Leu were detected using electrospray positive mode, 3.5 kV capillary voltage, 25 V cone voltage, 120°C source temperature, 250°C desolvation temperature, and 10 eV collision energy.
- the mass/charge ratio of the detected parent and daughter ions were 132.21 and 86.60, respectively.
- Example 7 Lys/Gln Separation Method
- the instramentation described above for the 19 amino acid separation was used, but the HPLC-MS/MS protocol was changed.
- Mobile phases were: A. 0.05% acetic acid in water and B. 100% acetonitrile, 0.05% acetic acid.
- the total HPLC run time was 1.5 min using the following gradient: 0 to 0.6 min, 100% A, 1 ml/min; 0.6 to 1.2 min, 100% B, 2 ml/min; 1.2 to 1.5 min, 100% A, 2 ml/min.
- Ile and Leu were detected using electrospray positive mode, 3.5 kV capillary voltage, 25 V cone voltage, 120°C source temperature, 250°C desolvation temperature, and 15 eV collision energy.
- the mass/charge ratio of the detected parent and daughter ions were 147.11 and 84.6, respectively.
- Chromosomal DNA was amplified by PCR and was sequenced using an ABI3700 sequencer (Applied Biosystems, Foster City, CA) as described previously (Jander et al., "Ethylmethanesulfonate Saturation Mutagenesis in Arabidopsis to Determine Frequency of Herbicide Resistance," Plant Physiol 131:139-146 (2003); Van Eenennaam et al., “Engineering Vitamin E Content: From Arabidopsis Mutant to Soy Oil,” Plant Cell 15:3007-3019 (2003), which are hereby incorporated by reference in their entirety).
- SNPs single nucleotide polymorphisms
- A1G08630 was amplified from the full-length cDNA clone U148646 (ABRC) using the primers AGTCGGATCCATGGTGATGAGAAGTGTGGATCT (SEQ ID NO: 19) and AGCTCTGCAGTTAGGTTCGGCTTGGTTCCTG (SEQ ID NO:20) and was cloned into the tetracycline-repressible yeast vector pCM185 (Gari et al., "A Set of Vectors with a Tetracycline-Regulatable Promoter System for Modulated Gene Expression in Saccharomyces cerevisiae," Yeast 13:837-848 (1997), which is hereby incorporated by reference in its entirety) using the restriction enzymes BamHI and Pstl.
- the mutant cDNA was amplified using the same primers as for the wild-type cDNA and was cloned into pCM185.
- Yeast cultures (40 ml) were grown overnight in SD medium supplemented with 20 ⁇ g/ml adenine, 30 ⁇ g/ml leucine, 40 ⁇ g/ml tryptophan, 20 ⁇ g/ml uracil, 20 ⁇ g/ml histidine, and 750 ⁇ g/ml glycine.
- Grade yeast extracts were prepared by glass bead disruption (Ausubel et al., "Cunent Protocols in Molecular Biology," Hoboken: John Wiley and Sons, Inc. (1998), which is hereby incorporated by reference in its entirety). Extracts were desalted using Econo-Pac 10DG columns (Bio-Rad, Hercules, CA).
- Thr aldolase reactions were carried out in 200 ⁇ l total volume with 100 mM Hepes/NaOH, pH 8.0, 50 ⁇ M pyridoxal-P, and 0, 1, 2, 5, 10, or 50 mM Thr as the substrate (Liu et al., "Gene Cloning, Biochemical Characterization and Physiological Role of a Thermostable Low-Specificity L-Threonine Aldolase from Escherichia coli," Eur J Biochem 255:220-226 (1998a), which is hereby incorporated by reference in its entirety).
- Arabidopsis seed extracts are shown in Figure 2 and the masses measured for each amino acid are listed in Table 1 (supra).
- the levels of free Cys and Gly in Arabidopsis seeds are to low too be quantified reliably by HPLC-MS/MS.
- Lys and Gin are separated by about 0.14 min in the same mass chromatogram, and Gin is considerably more abundant than Lys in Arabidopsis seeds.
- the tail of the Gin peak can adversely affect the quantitation of Lys in this assay.
- Leu and Ile are not separated by this method.
- Example 13 Mutant Screen
- the 1.5-min HPLC-MS/MS assay described above was sufficiently fast and reliable to use for a large-scale screen for Arabidopsis mutants with altered arnino acid content. Although the assay detects both leaf and seed amino acids with high efficiency, a mutant screen was chosen to be performed for alteration of free arnino acids in seeds. Two major factors were considered in this decision: the level of biological variability was quite a bit lower in seeds than leaves, presumably reflecting well characterized diurnal regulation of amino acid levels in green tissue (Coruzzi et al., "Amino Acids," In Buchanan et al., eds., Biochemistry and Molecular Biology of Plants, Rockville, MD: Am. Soc. Plant Physiol. Press, pp. 358-410 (2000), which is hereby incorporated by reference in its entirety), and seeds of crop plants are the main targets of efforts to alter amino acid levels.
- a total of 322 lines showed significantly increased amino acid levels (three standard deviations above the mean) in two different extractions of the same seed samples.
- at least one of the Asp- derived arnino acids (Ile, Lys, Met, and Thr) was increased in 103 mutant lines.
- These mutants were of particular interest due to the essential and sometimes limiting role of Asp-derived amino acids in human and animal diets.
- all of the 103 mutants affected in Asp-derived amino acids were grown together with wild-type plants in a replicated planting. Seeds were harvested and subjected to amino acid analysis by HPLC-MS/MS.
- the 25% of F 2 lines with the lowest levels of seed Thr were genotyped with five markers on each of the five chromosomes, and genetic linkage of the HST2 mutation was found to two markers on chromosome 1.
- Genotyping with additional markers nanowed the position of the HST2 mutation to a region of chromosome 1 between markers CER474622 on BAG T21E18 and CER432610 on BAG F7G19 (see www.arabidopsis.org/Cereon).
- Analysis of the sequence in this region identified a Thr aldolase homologue (AT1G08630; EC 4.1.2.5) as a candidate gene.
- Thr aldolase catalyzes the reversible reaction Thr ⁇ Gly + acetaldehyde in mammals and microbes
- Liu et al. "Glyl Gen of Saccharomyces cerevisiae Encodes a Low-Specificity L-Threonine Aldolase that Catalyzes Cleavage of L- ⁇ //o-Threonine and L-Threonine to Glycine: Expression of the Gene in Escherichia coli and Purification and Characterization of the Enzyme," Eur J Biochem 245:289-293 (1997); Liu et al., “Gene Cloning, Biochemical Characterization and Physiological Role of a Thermostable Low-Specificity L-Threonine Aldolase from Escherichia coli " Eur J Biochem 255:220-226 (1998a); Liu et al., " Gene Cloning, Nucleotide Sequencing, Purification, and
- AT1G08630 encodes an Arabidopsis Thr aldolase was strengthened by transformation of cDNA clones into yeast strain YM13 (glyl; shml; shm2), which is a Gly auxotroph due to mutations in Thr aldolase and both yeast Ser hydroxymethyltransferases (SHMT, EC 2.1.2.1) (McNeil et al., "Cloning and Molecular Characterization of Three Genes, Including Two Genes Encoding Serine Hydroxymethyltransferases, Whose Inactivation is Required to Render Yeast Auxotrophic for Glycine," J iol Chem 269:9155-9165 (1994); Monschau et al., "Identification of Saccharomyces Cerevisia
- Genome Initiative "Analysis of the Genome Sequence of the Flowering Plant,” Arabidopsis thaliana. Nature 408:796-815 (2000), which is hereby incorporated by reference in its entirety) identified another likely Thr aldolase (AT3G04520) on chromosome 3, with 70% amino acid sequence identity to the chromosome 1 gene (AT1G08630).
- AT3G04520 Thr aldolase
- AT1G08630 and AT3G04520 genes are proposed to be named THAI and THA2 (rHreonine aldolase), respectively.
- the mutation that was identified in line ⁇ ST2 is designated the thal-1 allele.
- Example 16 High-Throughput HPLC-MS/MS Assay for Screening Arabidopsis Mutants Yields Evidence That Threonine Aldolase Plays a Role in Seed Nutritional Quality [0126]
- the HPLC-MS/MS assay described herein allows determination of 18 amino acids from plant tissue in 1.5 minutes, which is 15 to 60- fold faster than traditional derivatization and reverse-phase HPLC. With the previous method, it would have been very time-consuming to screen 10,000 mutant families for altered seed arnino acid content.
- mutants were identified with increased levels of Ile, Lys, Met or Thr.
- the direct screening method employed could yield mutants affected in a variety of mechanisms, including altered biochemical or genetic regulation of pathway enzymes (including allosteric effects), increased amino acid transport, loading into the developing seeds, or reduced catabolism.
- mutant screen described herein is fundamentally different from previous approaches that have been used to identify plant amino acid genes.
- most previously known plant amino acid mutants were identified by selections using toxic amino acid analogues in seedling screens, toxic mixtures of arnino acids on seedlings, or transgenic expression of enzymes with altered regulation, direct screerring for free arnino acid levels in seeds was performed.
- mapping and sequencing of the AT1G08630 Thr aldolase gene from high seed Thr mutant HST2 (thai -I) identified a Glyl 14Arg missense mutation.
- a recessive thal-1 mutation might produce a 3:1 high: low threonine segregation ratio, because pooled F 3 seeds from individual F 2 plants were assayed.
- a heterozygous F 2 parent would produce seeds that individually segregate in a 1 :2: 1 Mendelian manner, resulting in pooled F 3 seeds that have elevated Thr levels compared to wild type, even though only 25% of all seeds are homozygous mutant.
- the purified maize and mung bean enzymes were reported to cleave L-allo- Thr (a non-natural substrate) and L-Ser, but not L-Thr.
- substrate specificity has been found for several purified SHMT enzymes including rat, rabbit, human, and E. coli (Ogawa et al., "Serine Hydroxymethyltransferase and Tlireonine Aldolase: Are They Identical? IntJ Biochem Cell Biol 32:289-301 (2000), which is hereby incorporated by reference in its entirety).
- Thr aldolases do not have the capacity to bind tetrahydro folate, wliich is necessary for the SHMT Ser cleavage reaction (Kielkopf et al., "X-ray Structures of Threonine Aldolase Complexes: Structural Basis of Substrate Recognition," Biochemistry 41:11711- 11720 (2002), which is hereby incorporated by reference in its entirety), and the Vma Km values for cleavage of Thr by Thr aldolases are much higher than those by SHMTs (Ogawa et al., "Serine Hydroxymethyltransferase and Threonine Aldolase: Are They Identical?
- Thr aldolase may serve to remove excess Thr.
- Thr aldolase may function as an alternate pathway for Gly biosynthesis in plants, in addition to the Gly produced during photorespiration and from 3-phosphoglycerate as a branch off of glycolysis (Bourguignon et al., "Serine and Glycine Metabolism in Higher Plants," In Singh, B.K., ed., Plant Amino Acids, Basel: Marcel Dekker, pp. 111-146 (1999), which is hereby incorporated by reference in its entirety).
- a third possible role for plant Thr aldolase is that the reaction Thr — Gly + acetaldehyde functions in the production of acetyl-CoA, which can be produced from acetaldehyde by the sequential action of acetaldehyde dehydrogenase and acetyl-CoA synthase.
- Thr aldolase might help to catalyze Thr biosynthesis, or perhaps reduce the amount of acetaldehyde produced in plants emerging from anoxic stress (Kursteiner et al., "The Pyruvate Decarboxylasel Gene of Arabidopsis is Required During Anoxia but not Other Environmental Stresses," Plant Physiol 132:968-978 (2003); Tsuji et al., 'Induction of Mitochondrial Aldehyde Dehydrogenase by Submergence Facilitates Oxidation of Acetaldehyde During Re- Aeration in Rice," FEBS Lett 546:369-373 (2003), which are hereby incorporated by reference in their entirety).
- the high-speed HPLC-MS/MS assay described herein can be easily applied to other plant species, animals, or microbes to determine amino acid content. Modifications of the tissue extraction and HPLC-MS/MS detection protocols would allow extension of this arnino acid assay to a more general metabolite profiling method. By using this assay for an Arabidopsis mutant screen, a mutation that causes high seed Thr levels by reducing the activity of Thr aldolase has been identified.
- TILLING Total Induced Localized Lesions IN Genomes
- Greene et al. "Spectrum of Chemically Induced Mutations from a Large-Scale Reverse-Genetic Screen in Arabidopsis," Genetics 164:731 -740 (2003); Till et al., “Large-Scale Discovery of Induced Point Mutations with High- Throughput Tilling,” Genome Res 13:524-530 (2003), which are hereby incorporated by reference in their entirety
- This method is being applied for targeted identification of mutations in rice (see, e.g., USDA-ARS project # 5306-21000-016-00) and maize (see, e.g., NSF award #0321510).
- Step 1 a mutagenized population of rice plants is generated by chemical mutagenesis, or is otherwise acquired.
- Step 2 likely threonine aldolases (for instance gi
- PCR primers are designed using the CODDLE program to amplify segments of about 1000 base pairs from the rice genome and end-label the products (Greene et al., "Spectrum of Chemically Induced Mutations from a Large- Scale Reverse-Genetic Screen in Arabidopsis," Genetics 164:731-740 (2003); Till et al., “Large-Scale Discovery of Induced Point Mutations with High-Throughput Tilling,” Genome Res 13:524-530 (2003), which are hereby incorporated by reference in their entirety).
- Step 4 primers from Step 3 threonine aldolase segments from pooled samples of DNA from the mutagenized rice population, CEL 1 nuclease is used to cleave single base pair DNA mismatches, and cleaved products are visualized on polyacrylamide gels (Greene et al., "Spectrum of Chemically Induced Mutations from a Large-Scale Reverse-Genetic Screen in Arabidopsis," Genetics 164:731-740 (2003); Till et al., “Large-Scale Discovery of Induced Point Mutations with High- Throughput Tilling," Genome Res 13:524-530 (2003), which are hereby incorporated by reference in their entirety).
- Step 5 individual plants from the pools that show mutations in Step 4 are re-assayed to identify the ones that carry mutations.
- Step 6 threonine aldolase is sequenced to determine the site of the mutations.
- Step 7 enzymatic assays and threonine measurements on the mutant plants are used to determine whether tlrreoriine aldolase has been inactivated.
- the approach outlined above can be applied to identify threonine aldolase mutations in rice or any other crop plant. Not only knockout mutations that completely abolish enzymatic activity, but also missense mutations that merely reduce enzymatic activity can be identified.
- RNA interference RNA interference
- RNA self-complementary, doublestranded "hairpin” RNA can be used to efficiently silence endogenous plant genes (Wesley et al., "Constmct Design for Efficient, Effective and High-Throughput Gene Silencing in Plants," Plant J 27:581-590 (2001), which is hereby incorporated by reference in its entirety).
- Threonine aldolase in soybean or other plants could be silenced by the introduction of such constmcts into the plants by methods such as particle bombardment or Agrobacterium-mediated transformation. Through reduction of threonine aldolase activity, these plants would have a higher tlireonine content.
- transgenic soybean plants with reduced threonine aldolase expression could be generated in the following manner: Step 1, soybean threonine aldolase genes (for instance gi
- RNA silencing constmcts are generated by cloning the soybean DNA into binary plant transformationvectors such as pHANNIB AL or pHELLSGATE (Wesley et al., "Constmct Design for Efficient, Effective and High- Throughput Gene Silencing in Plants," Plant J 27:581-590 (2001), which is hereby incorporated by reference in its entirety).
- PCR primers that would be used to amplify various crop plant threonine aldolase DNA sequences with appropriate restriction enzyme sites (Xhol + Kpnl and Xbal + C , respectively) for cloning into restriction sites of the the pHANNIBAL vector for plant transformation and gene silencing (Wesley et al., "Constmct Design for Efficient, Effective and High-Throughput Gene Silencing in Plants," Plant J 27:581-590 (2001), which is hereby incorporated by reference in its entirety) are listed below.
- Primer2 (Forward) (SEQ ID NO:23): 5 '-ATGCATGCTCTAGATTCGTGCCGTCCGGCACCATGGCCAACCTC-3'
- Primer2 (Forward) (SEQ ID NO:27): 5 '—ATGCATGCTCTAGAGAGGCGGAGATGGCCGCGGTCATGGGCAAG-3'
- Primer2 (Forward) (SEQ ID NO:35): 5 ' -ATGCATGCTCTAGAGAAAGAGGAACAGCTAATTCATAAAATTTA-3 '
- Primer2 (Forward) (SEQ ID NO:39): 5 ' -ATGCATGCTCTAGACTCCTCCCCACTCATCTTCTCTGGCCCAAC-3 '
- Primer2 (Forward) (SEQ ID NO:43): 5 ' -ATGCATGCTCTAGACTTCCAACATTACATGATATACAAGCGACA- Primer2 (Reverse) (SEQ ID NO:44):
- Primer2 (Forward) (SEQ ID NO:47): 5 ' -ATGCATGCTCTAGAGACGAGCATCCTTCTTCATTTTGCACAGGT-3 '
- PCR primers for cloning crop plant threonine aldolase DNA sequences into the recombination sites of the pHELLSGATE vector for plant transformation and gene silencing are listed below.
- Primer2 (SEQ ID NO:58): 5 ' -GGGGACCACTTTGTACAAGAAAGCTGGGTGGTGGTGGGATAATGCAGCGCCCCCGCCCC-3 '
- Primer2 (SEQ ID NO:60):
- Primerl (SEQ ID NO:61): 5' -GGGGACAAGTTTGTACAAAAAAGCAGGCTGACGAGCATCCTTCTTCATTTTGCACAGGT-3 '
- Step 3 vectors from Step 2 are used to generate transgenic soybeans by Agrobacterium-mediated transfonnation (Liu et al., "Efficient Agrobacterium Tumefaciens-Mediated Transformation of Soybeans Using an Embryonic Tip Regeneration System," Planta 219:1042-1049 (2004), which is hereby incorporated by reference in its entirety) or other methods.
- Step 4 enzymatic assays and tlireonine measurements on the transgenic plants are used to determine whether threonine aldolase has been inactivated.
- Inactivation of threonine aldolase by RNA interference could be used in a similar manner in other crop species. Different levels of silencing efficiency can result in an allelic series of plants with different levels of threonine aldolase activity.
- Example 19 Identification of a Transposon Insertion in Maize (Zea mays) Threonine Aldolase to Increase Threonine Content
- Plant genes can be inactivated by insertion of transposons or
- Agrobacterium T-DNA sequences Such insertions could also be used to inactivate threonine aldolase, thereby decreasing the level of activity of this enzyme and increasing the amount of free threonine in the plant.
- Activator Ac
- two commonly used transposable elements used for mutagenesis are Activator (Ac) (Brutnell and Conrad, “Transposon Tagging Using Activator (Ac) in Maize," Methods Mol Biol 236:157- 176 (2003); Kolkman et al., “Distribution of Activator (Ac) Throughout the Maize Genome for Use in Regional Mutagenesis," Genetics advance online publication:(2004), which are hereby incorporated by reference in their entirety),
- Step 3 a line with a nearby Activator (Ac) transposon insertion is identified in available collections (Kolkman et al., "Distribution of Activator (Ac) Throughout the Maize Genome for Use in Regional Mutagenesis," Genetics advance online publication: (2004), which is hereby incorporated by reference in its entirety).
- Step 4 Ac transposition is induced and, since Ac has a propensity to transpose to linked sites in the genome, some fraction of these transposition events will result in insertions in the threonine aldolase gene.
- Step 5 insertions in the threonine aldolase gene are identified by PCR using primers complementary to threonine aldolase and the Ac transposons.
- Step 6 knockout of threonine aldolase is confirmed by enzymatic activity assays and by measurement of plant threonine levels. Suitable primers complementary to maize threonine aldolase and the ends of the Ac transposon are described below.
- T- DNA insertion vector pROK2 (Alonso et al., "Genome- Wide Insertional Mutagenesis of Arabidopsis Thaliana,” Science 301 :653-657 (2003), which is hereby incorporated by reference in its entirety) is used to make a T-DNA insertion library in a given plant
- primers complementary to the ends of the T-DNA and complementary to plant threonine aldolase sequences would be used to amplify the insertion boundary by PCR. This amplified sequence would be verified by DNA sequencing. Primers specific for the ends of the pROK2 T-DNA and for crop plant threonine aldolase genes that could be used for this amplification are listed below.
- Plant threonine aldolase-specific primers for amplification of insertion boundaries Plant threonine aldolase-specific primers for amplification of insertion boundaries:
- Reverse primer (SEQ ID NO:78): 5 ' -GGGTAACATATTTGAAAGCTAGGATCTCGA-
- Canola (Brassica napus):
- threonine aldolases function as homotetramers (Ogawa et al., "Serine Hydroxymethyltransferase and Threomne Aldolase: Are They Identical?,” Int J Biochem Cell Biol 32:289-301 (2000), which is hereby incorporated by reference in its entirety), it may be possible to isolate a dominant negative mutation in a plant threonine aldolase, overproduce this mutant enzyme in an otherwise wild-type plant, inactivate wild-type threonine aldolase that forms a tetramer with the mutant enzyme, and thereby increase threonine content in the plant.
- Step 1 wild-type plant tlireonine aldolase is cloned into a yeast vector with an inducible promoter, for instance the GAL1/GAL10 galactose-inducible promoter in a plasmid such as pBM150 (Steel et al., "A Screen for Dominant
- Step 2 the plasmid constmct from Step 1 is used to rescue the glycine auxotrophy of yeast strain YM13 (McNeil et al., "Cloning and Molecular Characterization of Three Genes, Including Two Genes Encoding Serine Hydroxymethyltransferases, Whose Inactivation Is Required to Render Yeast Auxotrophic for Glycine," J Biol Chem 269:9155-9165 (1994); Monschau et al., "Identification of Saccharomyces Cerevisiae Glyl as a Threonine Aldolase: A Key Enzyme in Glycine Biosynthesis," FEMS Microbiol Lett 150:55-60 (1997); Woldman and Appling, "A General Method for Determining
- Step 3 wild-type plant threonine aldolase is cloned into a different vector with a different regulatable promoter, for instance pCM185 (Gari et al., "A Set of Vectors with a Tetracycline-Regulatable Promoter System for Modulated Gene Expression in Saccharomyces Cerevisiae,” Yeast 13:837-848 (1997), which is hereby incorporated by reference in its entirety), which has a tetracycline-repressible promoter.
- pCM185 a different regulatable promoter
- Step 4 the 5 construct from Step 3 is chemically mutagenized, the yeast strain in Step 2 is transformed, and colonies are selected on yeast minimal medium in the presence of tetracycline and the absence of glycine.
- Step 5 the colonies from Step 4 are replica- plated onto yeast minimal medium without tetracycline (to induce production of the mutated threonine aldolase) and without glycine, to identify colonies that are unable0 to grow under these conditions. This selection would identify mutated threonine aldolase whose production inactivates the wild-type threonine aldolase produced from the construct described in Steps 1 and 2.
- Step 6 the mutant threonine aldolase gene from Step 5 is sequenced to identify the mutation(s).
- Step 7 the mutant threonine aldolase from Step 5 is cloned into a plant transformation vector, for instance one of 5 the pCAMBIA T-DNA vectors (Roberts et al., "A Comprehensive Set of Modular Vectors for Advanced Manipulations and Efficient Transformation of Plants by Both Agrobacterium and Direct DNA Uptake Methods, www.Cambia.Org/” (2003), which is hereby incorporated by reference in its entirety), which can be used for Agrobacterium-mediated transformation, and is used to make a transgenic plantO overexpressing the mutant enzyme.
- a plant transformation vector for instance one of 5 the pCAMBIA T-DNA vectors (Roberts et al., "A Comprehensive Set of Modular Vectors for Advanced Manipulations and Efficient Transformation of Plants by Both Agrobacterium and Direct DNA Uptake Methods, www.Cambia.Org/” (2003), which is hereby incorporated by reference in its entirety), which can be used for Agrobacterium-
- a transgenic plant can be generated by particle bombardment (Taylor and Fauquet, "Microparticle Bombardment as a Tool in Plant Science and Agricultural Biotechnology," DNA Cell Biol 21 :963-977 (2002), which is hereby incorporated by reference in its entirety) or other methods.
- Step 8 inactivation of the wild-type enzyme in the plant is verified by5 enzymatic assays and determination of increased threonine content.
- Example 21 Expression of Wild Type Plant Threonine Aldolase in Mitochondria to Increase Threonine Content
- the threonine aldolase reaction is reversible, depending on the relativeO substrate concentrations. Therefore, by expressing threonine aldolase in a part of the plant with high glycine concentrations or glycine flux might result in the production of higher levels of threonine.
- Mitochondria are organelles in which glycine is converted to serine by the action of serine hydroxymethyltransferase ( Figure 7). Based on sequence comparisons, threonine aldolase appears to be a cytosolic enzyme in plants.
- threonine aldolase with a mitochondrial targeting sequence might allow the enzyme to function in threonine synthesis.
- Plant mitochondrial targeting sequences are known and have been used to target foreign proteins to mitochondria in transgenic plants (Ambard-Bretteville et al., "Discrete Mutations in the Presequence of Potato Formate Dehydrogenase Inhibit the in Vivo Targeting of Gfp Fusions into Mitochondria," Biochem Biophys Res Commun 311 :966-971 (2003); Guda et al., “Mitopred: A Web Server for the Prediction of Mitochondrial Proteins," Nucleic Acids Res 32:W372-374 (2004); Hwang et al., "Novel Targeting Signals Mediate the Sorting of Different Isoforms of the Tail- Anchored Membrane Protein Cytochrome B5 to Either Endoplasmic Reticulum or Mitochondria," Plant Cell 16:3002-3019
- Step 1 An example of one method by which threonine aldolase could be targeted to mitochondria is: Step 1, a threonine aldolase homolog in the plant of interest is identified by comparison to known, functional threonine aldolases from Arabidopsis or microorganisms.
- Step 2 the threonine aldolase gene is fused to a mitochondrial targeting sequence — for instance, that of potato formate dehydrogenase (Ambard-Bretteville et al., "Discrete Mutations in the Presequence of Potato Formate Dehydrogenase Inhibit the in Vivo Targeting of Gfp Fusions into Mitochondria," Biochem Biophys Res Commun 311 :966-971 (2003), which is hereby incorporated by reference in its entirety) — and is cloned into a plant transformation vector.
- a mitochondrial targeting sequence for instance, that of potato formate dehydrogenase (Ambard-Bretteville et al., "Discrete Mutations in the Presequence of Potato Formate Dehydrogenase Inhibit the in Vivo Targeting of Gfp Fusions into Mitochondria," Biochem Biophys Res Commun 311 :966-971 (2003), which is hereby
- Step 3 a plant is genetically transformed (e.g., by using Agrobacterium transformation, particle bombardment, or other transformation methods) with the constmct of a mitochondrial targeting sequence fused to threonine aldolase.
- Step 4 threonine aldolase enzymatic activity and tlireonine levels are measured in the transformed plant. Similar methods to that described above could be used to target tlireonine aldolase to other plant organelles that might have high glycine levels, for instance the peroxisome (Figure 7).
- mitochondrial targeting peptides include, for example, the following: (1) Potato formate dehydrogenase: ATGGCGATGAGTCGTGTAGCTTCTACAGCAGCTCGTGCTATTACT TCACCTTCATCCTTAGTTTTTACC (SEQ ID NO: 85)
- Example 22 Reduction of Plant Threonine Aldolase Activity, Combined with Increased Production of Isoleucine Biosynthetic Enzymes or Feedback-Insensitive Isoleucine Biosynthetic Enzymes, to Increase Isoleucine Content
- Threonine serves as a direct precursor for the amino acid isoleucine
- Figure 8 which is also a target for plant genetic engineering. Plants that have high threonine levels as a result of modification of threonine aldolase expression could be firrther engineered to have high isoleucine content. At least two of the enzymes (threonine aldolase and acetolactate synthase) acting between threonine and isoleucine are subject to feedback inhibition by downstream metabolites (Figure 8).
- the levels of isoleucine could be greatly increased in a threonine aldolase- altered plants by expressing feedback-insensitive versions of threonine deaminase (Garcia and Mourad, "A Site-Directed Mutagenesis Interrogation of the Carboxy- Terrninal End of Arabidopsis Thaliana Threonine Dehydratase/Deaminase Reveals a Synergistic Interaction between Two Effector-Binding Sites and Contributes to the Development of a Novel Selectable Marker," Plant Mol Biol 55:121-134 (2004); Mourad and King, "L-O-Methylthreonine-Resistant Mutant of Arabidopsis Defective in Isoleucine Feedback Regulation," Plant Physiol 107:43-52 (1995), which are hereby incorporated by reference in their entirety) and/or acetolactate synthase (Hervieu and Vaucheret, "A Single Amino Acid Change in Acetolac
- plants with elevated isoleucine levels could be engineered in the following manner: Step 1, plants with altered expression of threomne aldolase are created as described supra in Examples 17 to 21, or by other methods. Step 2, genes encoding threomne deaminase and/or acetolactate synthase are cloned into plasmid vectors, and mutations conferring feed-back insensitivity are created by site-directed mutagenesis. Step 3, mutated threonine deaminase and/or acetolactate synthase are cloned into plant transformation vectors.
- Step 4 plants are transformed to express mutated threonine deaminase and/or acetolactate synthase by Agrobacterium-mediated transformation, particle bombardment or other methods.
- Step 5 transformants with the desired phenotype are identified by enzymatic activity assays and isoleucine measurements.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51931303P | 2003-11-10 | 2003-11-10 | |
US60/519,313 | 2003-11-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005047472A2 true WO2005047472A2 (en) | 2005-05-26 |
WO2005047472A3 WO2005047472A3 (en) | 2006-05-26 |
Family
ID=34590390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/037369 WO2005047472A2 (en) | 2003-11-10 | 2004-11-12 | Increasing seed threonine content through alteration of threonine aldolase activity |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR046836A1 (es) |
WO (1) | WO2005047472A2 (es) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103468792A (zh) * | 2013-07-11 | 2013-12-25 | 江西省农业科学院水稻研究所 | 水稻双t-dna转基因非连锁整合的分子标记检测方法 |
CN107012162A (zh) * | 2016-01-28 | 2017-08-04 | 中国种子集团有限公司 | 农杆菌介导的棉花胚尖快速转化方法 |
WO2018038092A1 (ja) * | 2016-08-22 | 2018-03-01 | 日本たばこ産業株式会社 | 乾燥たばこ材料の生産方法 |
WO2018092072A1 (en) * | 2016-11-16 | 2018-05-24 | Cellectis | Methods for altering amino acid content in plants through frameshift mutations |
CN110272911A (zh) * | 2019-07-05 | 2019-09-24 | 四川大学 | AOX1a基因在提高植物耐旱性方面的应用 |
CN115109769A (zh) * | 2022-05-20 | 2022-09-27 | 华东理工大学 | 一种l-苏氨酸醛缩酶突变体以及在l-丝氨酸合成中的应用 |
CN117264976A (zh) * | 2023-09-19 | 2023-12-22 | 河北省农林科学院棉花研究所(河北省农林科学院特种经济作物研究所) | 一种棉花细胞壁强度调控基因及其应用 |
-
2004
- 2004-11-10 AR ARP040104142A patent/AR046836A1/es not_active Application Discontinuation
- 2004-11-12 WO PCT/US2004/037369 patent/WO2005047472A2/en active Application Filing
Non-Patent Citations (2)
Title |
---|
JANDER G. ET AL: 'Application of a High-Throughput HPLC-MS/MS Assay to Arabidopsis Mutant Screening; Evidence that Threonine Aldolase Plays a Role in Seed Nutritional Quality.' PLANT J. vol. 39, no. 3, August 2004, pages 465 - 475, XP002992770 * |
LEE S.J. ET AL: 'High-Throughput Screening Methods for Selecting L-Threonine Adolases with Improved Activity.' J MOL CATAL B: ENZY. vol. 26, no. 3-6, 2003, pages 265 - 272, XP002992768 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103468792A (zh) * | 2013-07-11 | 2013-12-25 | 江西省农业科学院水稻研究所 | 水稻双t-dna转基因非连锁整合的分子标记检测方法 |
CN107012162A (zh) * | 2016-01-28 | 2017-08-04 | 中国种子集团有限公司 | 农杆菌介导的棉花胚尖快速转化方法 |
JP7308870B2 (ja) | 2016-08-22 | 2023-07-14 | 日本たばこ産業株式会社 | 乾燥たばこ材料の生産方法 |
WO2018038092A1 (ja) * | 2016-08-22 | 2018-03-01 | 日本たばこ産業株式会社 | 乾燥たばこ材料の生産方法 |
CN109640707A (zh) * | 2016-08-22 | 2019-04-16 | 日本烟草产业株式会社 | 干燥烟草材料的生产方法 |
JPWO2018038092A1 (ja) * | 2016-08-22 | 2019-08-08 | 日本たばこ産業株式会社 | 乾燥たばこ材料の生産方法 |
JP2021072815A (ja) * | 2016-08-22 | 2021-05-13 | 日本たばこ産業株式会社 | 乾燥たばこ材料の生産方法 |
WO2018092072A1 (en) * | 2016-11-16 | 2018-05-24 | Cellectis | Methods for altering amino acid content in plants through frameshift mutations |
US11312972B2 (en) | 2016-11-16 | 2022-04-26 | Cellectis | Methods for altering amino acid content in plants through frameshift mutations |
CN110272911A (zh) * | 2019-07-05 | 2019-09-24 | 四川大学 | AOX1a基因在提高植物耐旱性方面的应用 |
CN115109769B (zh) * | 2022-05-20 | 2023-07-14 | 华东理工大学 | 一种l-苏氨酸醛缩酶突变体以及在l-丝氨酸合成中的应用 |
CN115109769A (zh) * | 2022-05-20 | 2022-09-27 | 华东理工大学 | 一种l-苏氨酸醛缩酶突变体以及在l-丝氨酸合成中的应用 |
CN117264976A (zh) * | 2023-09-19 | 2023-12-22 | 河北省农林科学院棉花研究所(河北省农林科学院特种经济作物研究所) | 一种棉花细胞壁强度调控基因及其应用 |
CN117264976B (zh) * | 2023-09-19 | 2024-03-19 | 河北省农林科学院棉花研究所(河北省农林科学院特种经济作物研究所) | 一种棉花细胞壁强度调控基因及其应用 |
Also Published As
Publication number | Publication date |
---|---|
AR046836A1 (es) | 2005-12-28 |
WO2005047472A3 (en) | 2006-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6515201B2 (en) | Anthranilate synthase gene and method of use thereof for conferring tryptophan overproduction | |
AU697331B2 (en) | Transgenic plants that exhibit enhanced nitrogen assimilation | |
US7323338B2 (en) | Plants characterized by an increased content of methionine and related metabolites, methods of generating same and uses thereof | |
EP2123753B1 (en) | Plant having increased yield of seeds | |
US20020069430A1 (en) | Transgenic plants that exhibit enhanced nitrogen assimilation | |
US7230165B2 (en) | Tocopherol biosynthesis related genes and uses thereof | |
AU9046098A (en) | Imidazolinone resistant AHAS mutants | |
WO1997026366A9 (en) | Anthranilate synthase gene and use thereof | |
Sarrobert et al. | Identification of an Arabidopsis thaliana mutant accumulating threonine resulting from mutation in a new dihydrodipicolinate synthase gene | |
Tzchori et al. | Lysine and threonine metabolism are subject to complex patterns of regulation in Arabidopsis | |
US6838276B2 (en) | Isolated nucleic acids encoding methylenetetrahydrofolate dehydrogenase enzymes | |
WO2005047472A2 (en) | Increasing seed threonine content through alteration of threonine aldolase activity | |
HUP0202613A2 (hu) | Növények megváltoztatott aminosav-tartalommal és eljárás előállításukra | |
KR20150045611A (ko) | 식물의 지베렐린 메커니즘에 관련된 OsGASD 유전자 및 이의 용도 | |
Kisaka et al. | Antisense suppression of glutamate decarboxylase in tomato (Lycopersicon esculentum L.) results in accumulation of glutamate in transgenic tomato fruits | |
AU2004239263B2 (en) | Plants with increased levels of one or more amino acids | |
US6184036B1 (en) | Ornithine biosynthesis enzymes | |
US20050251882A1 (en) | Sucrose phosphate synthase nucleic acid molecules and uses therefor | |
JP2002527039A (ja) | Ampデアミナーゼ | |
US20140216118A1 (en) | Compositions and Methods for Making and Biocontaining Auxotrophic Transgenic Plants | |
US6696292B1 (en) | Genes encoding sulfate assimilation proteins | |
US6939710B2 (en) | Genes encoding sulfate assimilation proteins | |
Shaver | Molecular analysis of transgenic maize modified for increased lysine biosynthesis | |
AU2002255254A1 (en) | Increased methionine in transgenic plants expressing mutant cystathionine gamma-synthase | |
KR20150069914A (ko) | LHT1 유전자의 ACC(1-Aminocyclopropane-1-Carboxylic acid) 수송체로서의 신규한 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |